 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0015403	thiamine uptake transmembrane transporter activity	1	1.015605e-4	3.745551e-1	3.745551e-1	9.846350e+3	1.015605e-4	1	1.015605e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	SLC19A2
GO Molecular Function	GO:0015563	uptake transmembrane transporter activity	2	1.138134e-4	4.197438e-1	2.098719e-1	8.786308e+3	1.138134e-4	1	1.138134e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	6.132358e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	SLC19A2
GO Molecular Function	GO:0008517	folic acid transporter activity	3	1.955116e-4	7.210468e-1	2.403489e-1	5.114786e+3	1.955116e-4	1	1.955116e-4	1.000000e+0	5	6.650594e-4	1.000000e+0	4.905478e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	SLC19A2
GO Molecular Function	GO:0090482	vitamin transmembrane transporter activity	4	2.186084e-4	8.062278e-1	2.015569e-1	4.574389e+3	2.186084e-4	1	2.186084e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	6.813353e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A2
GO Molecular Function	GO:1901474	azole transmembrane transporter activity	5	4.422672e-4	1.000000e+0	3.262163e-1	2.261076e+3	4.422672e-4	1	4.422672e-4	1.000000e+0	3	5.542315e-4	1.000000e+0	6.813353e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A2
GO Molecular Function	GO:0051184	cofactor transporter activity	6	8.259258e-4	1.000000e+0	5.076691e-1	1.210763e+3	8.259258e-4	1	8.259258e-4	1.000000e+0	7	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
GO Molecular Function	GO:0015238	drug transmembrane transporter activity	7	1.036883e-3	1.000000e+0	5.462892e-1	9.644294e+2	1.036883e-3	1	1.036883e-3	1.000000e+0	6	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	SLC19A2
GO Molecular Function	GO:0051183	vitamin transporter activity	8	1.084612e-3	1.000000e+0	5.000061e-1	9.219889e+2	1.084612e-3	1	1.084612e-3	1.000000e+0	7	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
GO Molecular Function	GO:0090484	drug transporter activity	9	1.203657e-3	1.000000e+0	4.932319e-1	8.308012e+2	1.203657e-3	1	1.203657e-3	1.000000e+0	7	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
GO Molecular Function	GO:1901682	sulfur compound transmembrane transporter activity	10	2.334460e-3	1.000000e+0	8.609488e-1	4.283645e+2	2.334460e-3	1	2.334460e-3	1.000000e+0	10	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	SLC19A2
GO Molecular Function	GO:0022891	substrate-specific transmembrane transporter activity	11	8.482288e-2	1.000000e+0	1.000000e+0	1.178927e+1	8.482288e-2	1	8.482288e-2	1.000000e+0	11	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	SLC19A2
GO Molecular Function	GO:0022857	transmembrane transporter activity	12	9.170810e-2	1.000000e+0	1.000000e+0	1.090416e+1	9.170810e-2	1	9.170810e-2	1.000000e+0	12	9.802388e-2	1.000000e+0	1.000000e+0	9.945424e+0	1.005488e-1	1	907	5.000000e-1	1.102536e-3	unnamed	SLC19A2
GO Molecular Function	GO:0022892	substrate-specific transporter activity	13	9.245642e-2	1.000000e+0	1.000000e+0	1.081591e+1	9.245642e-2	1	9.245642e-2	1.000000e+0	13	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	SLC19A2
GO Molecular Function	GO:0005215	transporter activity	14	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	14	1.269529e-1	1.000000e+0	1.000000e+0	7.618666e+0	1.312566e-1	1	1184	5.000000e-1	8.445946e-4	unnamed	SLC19A2
GO Biological Process	GO:0015888	thiamine transport	1	1.015605e-4	1.000000e+0	1.000000e+0	9.846350e+3	1.015605e-4	1	1.015605e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	SLC19A2
GO Biological Process	GO:0015884	folic acid transport	2	2.021323e-4	1.000000e+0	1.000000e+0	4.947256e+3	2.021323e-4	1	2.021323e-4	1.000000e+0	3	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	SLC19A2
GO Biological Process	GO:0042723	thiamine-containing compound metabolic process	3	6.327246e-4	1.000000e+0	1.000000e+0	1.580466e+3	6.327246e-4	1	6.327246e-4	1.000000e+0	2	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	SLC19A2
GO Biological Process	GO:0072337	modified amino acid transport	4	8.901594e-4	1.000000e+0	1.000000e+0	1.123394e+3	8.901594e-4	1	8.901594e-4	1.000000e+0	5	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
GO Biological Process	GO:0051181	cofactor transport	5	9.443147e-4	1.000000e+0	1.000000e+0	1.058969e+3	9.443147e-4	1	9.443147e-4	1.000000e+0	6	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	SLC19A2
GO Biological Process	GO:0051180	vitamin transport	6	1.367860e-3	1.000000e+0	1.000000e+0	7.310690e+2	1.367860e-3	1	1.367860e-3	1.000000e+0	7	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	SLC19A2
GO Biological Process	GO:0072348	sulfur compound transport	7	1.880044e-3	1.000000e+0	1.000000e+0	5.319024e+2	1.880044e-3	1	1.880044e-3	1.000000e+0	8	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	SLC19A2
GO Biological Process	GO:0045117	azole transport	8	1.976932e-3	1.000000e+0	1.000000e+0	5.058343e+2	1.976932e-3	1	1.976932e-3	1.000000e+0	4	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	SLC19A2
GO Biological Process	GO:0015893	drug transport	9	3.117582e-3	1.000000e+0	1.000000e+0	3.207614e+2	3.117582e-3	1	3.117582e-3	1.000000e+0	9	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	SLC19A2
GO Biological Process	GO:0006835	dicarboxylic acid transport	10	5.360935e-3	1.000000e+0	1.000000e+0	1.865346e+2	5.360935e-3	1	5.360935e-3	1.000000e+0	10	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	SLC19A2
GO Biological Process	GO:0072527	pyrimidine-containing compound metabolic process	11	6.706757e-3	1.000000e+0	1.000000e+0	1.491033e+2	6.706757e-3	1	6.706757e-3	1.000000e+0	11	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	SLC19A2
GO Biological Process	GO:0006767	water-soluble vitamin metabolic process	12	8.493979e-3	1.000000e+0	1.000000e+0	1.177305e+2	8.493979e-3	1	8.493979e-3	1.000000e+0	12	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	SLC19A2
GO Biological Process	GO:0006766	vitamin metabolic process	13	1.089445e-2	1.000000e+0	1.000000e+0	9.178985e+1	1.089445e-2	1	1.089445e-2	1.000000e+0	13	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	SLC19A2
GO Biological Process	GO:0006865	amino acid transport	14	1.137929e-2	1.000000e+0	1.000000e+0	8.787896e+1	1.137929e-2	1	1.137929e-2	1.000000e+0	14	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	SLC19A2
GO Biological Process	GO:0046942	carboxylic acid transport	15	1.899186e-2	1.000000e+0	1.000000e+0	5.265415e+1	1.899186e-2	1	1.899186e-2	1.000000e+0	15	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	SLC19A2
GO Biological Process	GO:0006790	sulfur compound metabolic process	16	2.820341e-2	1.000000e+0	1.000000e+0	3.545671e+1	2.820341e-2	1	2.820341e-2	1.000000e+0	16	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	SLC19A2
GO Biological Process	GO:0015711	organic anion transport	17	2.827900e-2	1.000000e+0	1.000000e+0	3.536193e+1	2.827900e-2	1	2.827900e-2	1.000000e+0	17	3.319999e-2	1.000000e+0	1.000000e+0	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	SLC19A2
GO Biological Process	GO:0006820	anion transport	18	3.528482e-2	1.000000e+0	1.000000e+0	2.834080e+1	3.528482e-2	1	3.528482e-2	1.000000e+0	19	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	SLC19A2
GO Biological Process	GO:0071705	nitrogen compound transport	19	3.671157e-2	1.000000e+0	1.000000e+0	2.723937e+1	3.671157e-2	1	3.671157e-2	1.000000e+0	20	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	SLC19A2
GO Biological Process	GO:0042493	response to drug	20	4.125969e-2	1.000000e+0	1.000000e+0	2.423673e+1	4.125969e-2	1	4.125969e-2	1.000000e+0	18	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	SLC19A2
GO Biological Process	GO:0006811	ion transport	21	1.070764e-1	1.000000e+0	1.000000e+0	9.339125e+0	1.070764e-1	1	1.070764e-1	1.000000e+0	21	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	SLC19A2
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	22	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	22	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	SLC19A2
GO Biological Process	GO:0071702	organic substance transport	23	1.396970e-1	1.000000e+0	1.000000e+0	7.158351e+0	1.396970e-1	1	1.396970e-1	1.000000e+0	23	1.786811e-1	1.000000e+0	1.000000e+0	5.334418e+0	1.874619e-1	1	1691	5.000000e-1	5.913661e-4	unnamed	SLC19A2
GO Biological Process	GO:0044281	small molecule metabolic process	24	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	24	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	SLC19A2
GO Biological Process	GO:0044765	single-organism transport	25	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	25	2.680389e-1	1.000000e+0	1.000000e+0	3.461435e+0	2.888975e-1	1	2606	5.000000e-1	3.837299e-4	unnamed	SLC19A2
GO Biological Process	GO:0044710	single-organism metabolic process	26	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	26	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	SLC19A2
GO Biological Process	GO:0006810	transport	27	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	27	3.291182e-1	1.000000e+0	1.000000e+0	2.763634e+0	3.618425e-1	1	3264	5.000000e-1	3.063725e-4	unnamed	SLC19A2
GO Biological Process	GO:0051234	establishment of localization	28	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	29	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	SLC19A2
GO Biological Process	GO:0042221	response to chemical stimulus	29	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	28	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	SLC19A2
GO Biological Process	GO:0051179	localization	30	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	30	3.970433e-1	1.000000e+0	1.000000e+0	2.237227e+0	4.469819e-1	1	4032	5.000000e-1	2.480159e-4	unnamed	SLC19A2
GO Biological Process	GO:0046483	heterocycle metabolic process	31	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	31	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	SLC19A2
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	32	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	32	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	SLC19A2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	33	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	33	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	SLC19A2
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	34	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	34	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	SLC19A2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	35	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	35	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	SLC19A2
GO Biological Process	GO:0050896	response to stimulus	36	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	36	6.177696e-1	1.000000e+0	1.000000e+0	1.309787e+0	7.634832e-1	1	6887	5.000000e-1	1.452011e-4	unnamed	SLC19A2
GO Biological Process	GO:0044237	cellular metabolic process	37	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	37	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	SLC19A2
GO Biological Process	GO:0071704	organic substance metabolic process	38	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	38	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	SLC19A2
GO Biological Process	GO:0008152	metabolic process	39	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	39	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	SLC19A2
GO Biological Process	GO:0044699	single-organism process	40	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	40	8.529291e-1	1.000000e+0	1.000000e+0	8.110502e-1	1.232969e+0	1	11122	5.000000e-1	8.991189e-5	unnamed	SLC19A2
GO Biological Process	GO:0009987	cellular process	41	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	41	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	SLC19A2
GO Cellular Component	GO:0005886	plasma membrane	1	4.126577e-1	1.000000e+0	1.000000e+0	2.423316e+0	4.126577e-1	1	4.126577e-1	1.000000e+0	1	4.264607e-1	1.000000e+0	1.000000e+0	2.060416e+0	4.853390e-1	1	4378	5.000000e-1	2.284148e-4	unnamed	SLC19A2
GO Cellular Component	GO:0071944	cell periphery	2	4.194602e-1	1.000000e+0	1.000000e+0	2.384017e+0	4.194602e-1	1	4.194602e-1	1.000000e+0	2	4.347424e-1	1.000000e+0	1.000000e+0	2.014854e+0	4.963140e-1	1	4477	5.000000e-1	2.233639e-4	unnamed	SLC19A2
GO Cellular Component	GO:0016021	integral to membrane	3	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	3	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	SLC19A2
GO Cellular Component	GO:0031224	intrinsic to membrane	4	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	4	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	SLC19A2
GO Cellular Component	GO:0005634	nucleus	5	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	5	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	CCDC181
GO Cellular Component	GO:0044425	membrane part	6	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	6	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	SLC19A2
GO Cellular Component	GO:0016020	membrane	7	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	9	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	SLC19A2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	8	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	10	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	CCDC181
GO Cellular Component	GO:0043227	membrane-bounded organelle	9	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	11	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	CCDC181
GO Cellular Component	GO:0043229	intracellular organelle	10	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	12	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	CCDC181
GO Cellular Component	GO:0043226	organelle	11	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	13	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	CCDC181
GO Cellular Component	GO:0044424	intracellular part	12	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	14	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	CCDC181
GO Cellular Component	GO:0005622	intracellular	13	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	15	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	CCDC181
GO Cellular Component	GO:0044464	cell part	14	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	7	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	CCDC181,SLC19A2
GO Cellular Component	GO:0005623	cell	15	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	8	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	CCDC181,SLC19A2
Mouse Phenotype	MP:0005505	increased platelet cell number	1	5.124781e-3	1.000000e+0	1.000000e+0	1.951303e+2	5.124781e-3	1	5.124781e-3	1.000000e+0	5	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0004740	sensorineural hearing loss	2	5.184031e-3	1.000000e+0	1.000000e+0	1.929001e+2	5.184031e-3	1	5.184031e-3	1.000000e+0	1	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0004398	cochlear inner hair cell degeneration	3	6.147546e-3	1.000000e+0	1.000000e+0	1.626665e+2	6.147546e-3	1	6.147546e-3	1.000000e+0	2	5.093135e-3	1.000000e+0	1.000000e+0	1.960978e+2	5.099496e-3	1	46	5.000000e-1	2.173913e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0004736	abnormal distortion product otoacoustic emission	4	7.792838e-3	1.000000e+0	1.000000e+0	1.283229e+2	7.792838e-3	1	7.792838e-3	1.000000e+0	3	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0006336	abnormal otoacoustic response	5	7.823985e-3	1.000000e+0	1.000000e+0	1.278121e+2	7.823985e-3	1	7.823985e-3	1.000000e+0	4	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0004404	cochlear outer hair cell degeneration	6	7.833827e-3	1.000000e+0	1.000000e+0	1.276515e+2	7.833827e-3	1	7.833827e-3	1.000000e+0	6	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0008261	arrest of male meiosis	7	9.348667e-3	1.000000e+0	1.000000e+0	1.069671e+2	9.348667e-3	1	9.348667e-3	1.000000e+0	8	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004362	cochlear hair cell degeneration	8	1.060731e-2	1.000000e+0	1.000000e+0	9.427462e+1	1.060731e-2	1	1.060731e-2	1.000000e+0	7	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	SLC19A2
Mouse Phenotype	MP:0005169	abnormal male meiosis	9	1.271718e-2	1.000000e+0	1.000000e+0	7.863377e+1	1.271718e-2	1	1.271718e-2	1.000000e+0	13	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001601	abnormal myelopoiesis	10	1.302171e-2	1.000000e+0	1.000000e+0	7.679483e+1	1.302171e-2	1	1.302171e-2	1.000000e+0	11	1.347939e-2	1.000000e+0	1.000000e+0	7.393852e+1	1.352475e-2	1	122	5.000000e-1	8.196721e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0006380	abnormal spermatid morphology	11	1.335759e-2	1.000000e+0	1.000000e+0	7.486378e+1	1.335759e-2	1	1.335759e-2	1.000000e+0	10	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005159	azoospermia	12	1.395800e-2	1.000000e+0	1.000000e+0	7.164348e+1	1.395800e-2	1	1.395800e-2	1.000000e+0	18	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001930	abnormal meiosis	13	1.460860e-2	1.000000e+0	1.000000e+0	6.845283e+1	1.460860e-2	1	1.460860e-2	1.000000e+0	18	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001155	arrest of spermatogenesis	14	1.568035e-2	1.000000e+0	1.000000e+0	6.377410e+1	1.568035e-2	1	1.568035e-2	1.000000e+0	23	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001117	absent gametes	15	1.602344e-2	1.000000e+0	1.000000e+0	6.240858e+1	1.602344e-2	1	1.602344e-2	1.000000e+0	24	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004393	abnormal cochlear inner hair cell morphology	16	1.602619e-2	1.000000e+0	1.000000e+0	6.239787e+1	1.602619e-2	1	1.602619e-2	1.000000e+0	9	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002891	increased insulin sensitivity	17	1.830530e-2	1.000000e+0	1.000000e+0	5.462899e+1	1.830530e-2	1	1.830530e-2	1.000000e+0	14	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004806	absent germ cells	18	1.845597e-2	1.000000e+0	1.000000e+0	5.418301e+1	1.845597e-2	1	1.845597e-2	1.000000e+0	26	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0011898	abnormal platelet cell number	19	1.861338e-2	1.000000e+0	1.000000e+0	5.372479e+1	1.861338e-2	1	1.861338e-2	1.000000e+0	28	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004399	abnormal cochlear outer hair cell morphology	20	1.966933e-2	1.000000e+0	1.000000e+0	5.084058e+1	1.966933e-2	1	1.966933e-2	1.000000e+0	12	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002875	decreased erythrocyte cell number	21	2.021847e-2	1.000000e+0	1.000000e+0	4.945973e+1	2.021847e-2	1	2.021847e-2	1.000000e+0	27	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004720	abnormal platelet morphology	22	2.260848e-2	1.000000e+0	1.000000e+0	4.423119e+1	2.260848e-2	1	2.260848e-2	1.000000e+0	35	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000228	abnormal thrombopoiesis	23	2.281943e-2	1.000000e+0	1.000000e+0	4.382231e+1	2.281943e-2	1	2.281943e-2	1.000000e+0	37	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0011967	increased or absent threshold for auditory brainstem response	24	2.315799e-2	1.000000e+0	1.000000e+0	4.318163e+1	2.315799e-2	1	2.315799e-2	1.000000e+0	16	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0006325	impaired hearing	25	2.398207e-2	1.000000e+0	1.000000e+0	4.169782e+1	2.398207e-2	1	2.398207e-2	1.000000e+0	15	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002622	abnormal cochlear hair cell morphology	26	2.482427e-2	1.000000e+0	1.000000e+0	4.028315e+1	2.482427e-2	1	2.482427e-2	1.000000e+0	17	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004852	decreased testis weight	27	2.496633e-2	1.000000e+0	1.000000e+0	4.005394e+1	2.496633e-2	1	2.496633e-2	1.000000e+0	39	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002417	abnormal megakaryocyte morphology	28	2.512167e-2	1.000000e+0	1.000000e+0	3.980628e+1	2.512167e-2	1	2.512167e-2	1.000000e+0	42	2.949024e-2	1.000000e+0	1.000000e+0	3.365858e+1	2.971010e-2	1	268	5.000000e-1	3.731343e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002413	abnormal megakaryocyte progenitor cell morphology	29	2.594276e-2	1.000000e+0	1.000000e+0	3.854641e+1	2.594276e-2	1	2.594276e-2	1.000000e+0	44	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000045	abnormal hair cell morphology	30	2.603596e-2	1.000000e+0	1.000000e+0	3.840842e+1	2.603596e-2	1	2.603596e-2	1.000000e+0	18	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000042	abnormal organ of Corti morphology	31	2.603731e-2	1.000000e+0	1.000000e+0	3.840643e+1	2.603731e-2	1	2.603731e-2	1.000000e+0	22	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003308	abnormal cochlear sensory epithelium morphology	32	2.627385e-2	1.000000e+0	1.000000e+0	3.806065e+1	2.627385e-2	1	2.627385e-2	1.000000e+0	18	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001586	abnormal erythrocyte cell number	33	2.631922e-2	1.000000e+0	1.000000e+0	3.799505e+1	2.631922e-2	1	2.631922e-2	1.000000e+0	38	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002727	decreased circulating insulin level	34	2.672040e-2	1.000000e+0	1.000000e+0	3.742458e+1	2.672040e-2	1	2.672040e-2	1.000000e+0	33	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004850	abnormal testis weight	35	2.756270e-2	1.000000e+0	1.000000e+0	3.628092e+1	2.756270e-2	1	2.756270e-2	1.000000e+0	43	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003169	abnormal scala media morphology	36	2.994348e-2	1.000000e+0	1.000000e+0	3.339625e+1	2.994348e-2	1	2.994348e-2	1.000000e+0	28	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004738	abnormal auditory brainstem response	37	3.000432e-2	1.000000e+0	1.000000e+0	3.332853e+1	3.000432e-2	1	3.000432e-2	1.000000e+0	28	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000972	abnormal mechanoreceptor morphology	38	3.044264e-2	1.000000e+0	1.000000e+0	3.284866e+1	3.044264e-2	1	3.044264e-2	1.000000e+0	25	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005293	impaired glucose tolerance	39	3.073714e-2	1.000000e+0	1.000000e+0	3.253393e+1	3.073714e-2	1	3.073714e-2	1.000000e+0	35	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000031	abnormal cochlea morphology	40	3.341625e-2	1.000000e+0	1.000000e+0	2.992556e+1	3.341625e-2	1	3.341625e-2	1.000000e+0	32	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0006335	abnormal hearing electrophysiology	41	3.344369e-2	1.000000e+0	1.000000e+0	2.990100e+1	3.344369e-2	1	3.344369e-2	1.000000e+0	31	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002673	abnormal sperm number	42	3.444445e-2	1.000000e+0	1.000000e+0	2.903225e+1	3.444445e-2	1	3.444445e-2	1.000000e+0	48	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000035	abnormal membranous labyrinth morphology	43	3.561089e-2	1.000000e+0	1.000000e+0	2.808130e+1	3.561089e-2	1	3.561089e-2	1.000000e+0	34	2.522619e-2	1.000000e+0	1.000000e+0	3.939083e+1	2.538662e-2	1	229	5.000000e-1	4.366812e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001393	ataxia	44	3.690969e-2	1.000000e+0	1.000000e+0	2.709315e+1	3.690969e-2	1	3.690969e-2	1.000000e+0	45	3.156421e-2	1.000000e+0	1.000000e+0	3.143031e+1	3.181642e-2	1	287	5.000000e-1	3.484321e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004901	decreased male germ cell number	45	3.727557e-2	1.000000e+0	1.000000e+0	2.682722e+1	3.727557e-2	1	3.727557e-2	1.000000e+0	51	4.092392e-2	1.000000e+0	1.000000e+0	2.418365e+1	4.135026e-2	1	373	5.000000e-1	2.680965e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0009763	increased sensitivity to induced morbidity/mortality	46	3.731243e-2	1.000000e+0	1.000000e+0	2.680072e+1	3.731243e-2	1	3.731243e-2	1.000000e+0	52	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000026	abnormal inner ear morphology	47	3.941211e-2	1.000000e+0	1.000000e+0	2.537291e+1	3.941211e-2	1	3.941211e-2	1.000000e+0	40	2.774202e-2	1.000000e+0	1.000000e+0	3.579563e+1	2.793637e-2	1	252	5.000000e-1	3.968254e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003224	neuron degeneration	48	4.054575e-2	1.000000e+0	1.000000e+0	2.466350e+1	4.054575e-2	1	4.054575e-2	1.000000e+0	47	3.472547e-2	1.000000e+0	1.000000e+0	2.854589e+1	3.503132e-2	1	316	5.000000e-1	3.164557e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001963	abnormal hearing physiology	49	4.097916e-2	1.000000e+0	1.000000e+0	2.440264e+1	4.097916e-2	1	4.097916e-2	1.000000e+0	41	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001124	abnormal gametes	50	4.207952e-2	1.000000e+0	1.000000e+0	2.376453e+1	4.207952e-2	1	4.207952e-2	1.000000e+0	56	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001560	abnormal circulating insulin level	51	4.326502e-2	1.000000e+0	1.000000e+0	2.311336e+1	4.326502e-2	1	4.326502e-2	1.000000e+0	49	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001147	small testis	52	4.463578e-2	1.000000e+0	1.000000e+0	2.240355e+1	4.463578e-2	1	4.463578e-2	1.000000e+0	57	4.807612e-2	1.000000e+0	1.000000e+0	2.054784e+1	4.866693e-2	1	439	5.000000e-1	2.277904e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002209	decreased germ cell number	53	4.466922e-2	1.000000e+0	1.000000e+0	2.238678e+1	4.466922e-2	1	4.466922e-2	1.000000e+0	55	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005291	abnormal glucose tolerance	54	4.475825e-2	1.000000e+0	1.000000e+0	2.234225e+1	4.475825e-2	1	4.475825e-2	1.000000e+0	50	3.951200e-2	1.000000e+0	1.000000e+0	2.505694e+1	3.990910e-2	1	360	5.000000e-1	2.777778e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003878	abnormal ear physiology	55	4.589014e-2	1.000000e+0	1.000000e+0	2.179117e+1	4.589014e-2	1	4.589014e-2	1.000000e+0	46	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0006362	abnormal male germ cell morphology	56	4.700263e-2	1.000000e+0	1.000000e+0	2.127540e+1	4.700263e-2	1	4.700263e-2	1.000000e+0	59	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0004849	abnormal testis size	57	4.871329e-2	1.000000e+0	1.000000e+0	2.052828e+1	4.871329e-2	1	4.871329e-2	1.000000e+0	58	5.185810e-2	1.000000e+0	1.000000e+0	1.903059e+1	5.254698e-2	1	474	5.000000e-1	2.109705e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001116	small gonad	58	4.956812e-2	1.000000e+0	1.000000e+0	2.017426e+1	4.956812e-2	1	4.956812e-2	1.000000e+0	59	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002229	neurodegeneration	59	4.985683e-2	1.000000e+0	1.000000e+0	2.005743e+1	4.985683e-2	1	4.985683e-2	1.000000e+0	53	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001657	abnormal induced morbidity/mortality	60	5.088453e-2	1.000000e+0	1.000000e+0	1.965234e+1	5.088453e-2	1	5.088453e-2	1.000000e+0	68	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001925	male infertility	61	5.253588e-2	1.000000e+0	1.000000e+0	1.903461e+1	5.253588e-2	1	5.253588e-2	1.000000e+0	62	5.520156e-2	1.000000e+0	1.000000e+0	1.786238e+1	5.598359e-2	1	505	5.000000e-1	1.980198e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002211	abnormal primary sex determination	62	5.292252e-2	1.000000e+0	1.000000e+0	1.889555e+1	5.292252e-2	1	5.292252e-2	1.000000e+0	61	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001156	abnormal spermatogenesis	63	5.407573e-2	1.000000e+0	1.000000e+0	1.849258e+1	5.407573e-2	1	5.407573e-2	1.000000e+0	66	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002208	abnormal germ cell morphology	64	5.558182e-2	1.000000e+0	1.000000e+0	1.799149e+1	5.558182e-2	1	5.558182e-2	1.000000e+0	67	6.004447e-2	1.000000e+0	1.000000e+0	1.640091e+1	6.097223e-2	1	550	5.000000e-1	1.818182e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002210	abnormal sex determination	65	5.670465e-2	1.000000e+0	1.000000e+0	1.763524e+1	5.670465e-2	1	5.670465e-2	1.000000e+0	65	5.832397e-2	1.000000e+0	1.000000e+0	1.689232e+1	5.919849e-2	1	534	5.000000e-1	1.872659e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002447	abnormal erythrocyte morphology	66	5.809647e-2	1.000000e+0	1.000000e+0	1.721275e+1	5.809647e-2	1	5.809647e-2	1.000000e+0	71	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001146	abnormal testis morphology	67	6.130724e-2	1.000000e+0	1.000000e+0	1.631129e+1	6.130724e-2	1	6.130724e-2	1.000000e+0	70	6.272959e-2	1.000000e+0	1.000000e+0	1.568783e+1	6.374369e-2	1	575	5.000000e-1	1.739130e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002102	abnormal ear morphology	68	6.230597e-2	1.000000e+0	1.000000e+0	1.604983e+1	6.230597e-2	1	6.230597e-2	1.000000e+0	54	4.406985e-2	1.000000e+0	1.000000e+0	2.243905e+1	4.456516e-2	1	402	5.000000e-1	2.487562e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000245	abnormal erythropoiesis	69	6.477947e-2	1.000000e+0	1.000000e+0	1.543699e+1	6.477947e-2	1	6.477947e-2	1.000000e+0	73	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001929	abnormal gametogenesis	70	6.671849e-2	1.000000e+0	1.000000e+0	1.498835e+1	6.671849e-2	1	6.671849e-2	1.000000e+0	75	7.236424e-2	1.000000e+0	1.000000e+0	1.356466e+1	7.372097e-2	1	665	5.000000e-1	1.503759e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0009205	abnormal internal male genitalia morphology	71	7.063478e-2	1.000000e+0	1.000000e+0	1.415733e+1	7.063478e-2	1	7.063478e-2	1.000000e+0	74	7.076192e-2	1.000000e+0	1.000000e+0	1.387769e+1	7.205809e-2	1	650	5.000000e-1	1.538462e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0009198	abnormal male genitalia morphology	72	7.377140e-2	1.000000e+0	1.000000e+0	1.355539e+1	7.377140e-2	1	7.377140e-2	1.000000e+0	76	7.247101e-2	1.000000e+0	1.000000e+0	1.354429e+1	7.383183e-2	1	666	5.000000e-1	1.501502e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003312	abnormal locomotor coordination	73	7.384015e-2	1.000000e+0	1.000000e+0	1.354277e+1	7.384015e-2	1	7.384015e-2	1.000000e+0	69	6.154861e-2	1.000000e+0	1.000000e+0	1.599379e+1	6.252425e-2	1	564	5.000000e-1	1.773050e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000965	abnormal sensory neuron morphology	74	7.398278e-2	1.000000e+0	1.000000e+0	1.351666e+1	7.398278e-2	1	7.398278e-2	1.000000e+0	63	5.574028e-2	1.000000e+0	1.000000e+0	1.768725e+1	5.653789e-2	1	510	5.000000e-1	1.960784e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005377	hearing/vestibular/ear phenotype	75	7.629812e-2	1.000000e+0	1.000000e+0	1.310648e+1	7.629812e-2	1	7.629812e-2	1.000000e+0	64	5.627884e-2	1.000000e+0	1.000000e+0	1.751553e+1	5.709218e-2	1	515	5.000000e-1	1.941748e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001924	infertility	76	7.848077e-2	1.000000e+0	1.000000e+0	1.274198e+1	7.848077e-2	1	7.848077e-2	1.000000e+0	77	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003698	abnormal male reproductive system physiology	77	8.181879e-2	1.000000e+0	1.000000e+0	1.222213e+1	8.181879e-2	1	8.181879e-2	1.000000e+0	82	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000653	abnormal sex gland morphology	78	8.328551e-2	1.000000e+0	1.000000e+0	1.200689e+1	8.328551e-2	1	8.328551e-2	1.000000e+0	80	8.088659e-2	1.000000e+0	1.000000e+0	1.210805e+1	8.258966e-2	1	745	5.000000e-1	1.342282e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0000959	abnormal somatic sensory system morphology	79	8.615818e-2	1.000000e+0	1.000000e+0	1.160656e+1	8.615818e-2	1	8.615818e-2	1.000000e+0	72	6.669653e-2	1.000000e+0	1.000000e+0	1.473938e+1	6.784546e-2	1	612	5.000000e-1	1.633987e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005418	abnormal circulating hormone level	80	8.615845e-2	1.000000e+0	1.000000e+0	1.160652e+1	8.615845e-2	1	8.615845e-2	1.000000e+0	79	8.003612e-2	1.000000e+0	1.000000e+0	1.223948e+1	8.170279e-2	1	737	5.000000e-1	1.356852e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0005460	abnormal leukopoiesis	81	8.694600e-2	1.000000e+0	1.000000e+0	1.150139e+1	8.694600e-2	1	8.694600e-2	1.000000e+0	85	9.306856e-2	1.000000e+0	1.000000e+0	1.048895e+1	9.533840e-2	1	860	5.000000e-1	1.162791e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002078	abnormal glucose homeostasis	82	8.818097e-2	1.000000e+0	1.000000e+0	1.134032e+1	8.818097e-2	1	8.818097e-2	1.000000e+0	81	8.141793e-2	1.000000e+0	1.000000e+0	1.202733e+1	8.314395e-2	1	750	5.000000e-1	1.333333e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0011181	increased hematopoietic cell number	83	9.359664e-2	1.000000e+0	1.000000e+0	1.068414e+1	9.359664e-2	1	9.359664e-2	1.000000e+0	86	1.045399e-1	1.000000e+0	1.000000e+0	9.309082e+0	1.074220e-1	1	969	5.000000e-1	1.031992e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0001516	abnormal motor coordination/ balance	84	9.929128e-2	1.000000e+0	1.000000e+0	1.007138e+1	9.929128e-2	1	9.929128e-2	1.000000e+0	78	7.897249e-2	1.000000e+0	1.000000e+0	1.240784e+1	8.059420e-2	1	727	5.000000e-1	1.375516e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0003953	abnormal hormone level	85	1.023291e-1	1.000000e+0	1.000000e+0	9.772394e+0	1.023291e-1	1	1.023291e-1	1.000000e+0	84	9.095579e-2	1.000000e+0	1.000000e+0	1.073869e+1	9.312122e-2	1	840	5.000000e-1	1.190476e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002398	abnormal bone marrow cell morphology/development	86	1.085064e-1	1.000000e+0	1.000000e+0	9.216047e+0	1.085064e-1	1	1.085064e-1	1.000000e+0	88	1.211425e-1	1.000000e+0	1.000000e+0	7.996897e+0	1.250485e-1	1	1128	5.000000e-1	8.865248e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0011182	decreased hematopoietic cell number	87	1.093948e-1	1.000000e+0	1.000000e+0	9.141200e+0	1.093948e-1	1	1.093948e-1	1.000000e+0	89	1.236350e-1	1.000000e+0	1.000000e+0	7.830295e+0	1.277091e-1	1	1152	5.000000e-1	8.680556e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002752	abnormal somatic nervous system morphology	88	1.122886e-1	1.000000e+0	1.000000e+0	8.905622e+0	1.122886e-1	1	1.122886e-1	1.000000e+0	83	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	SLC19A2
Mouse Phenotype	MP:0002160	abnormal reproductive system morphology	89	1.137433e-1	1.000000e+0	1.000000e+0	8.791730e+0	1.137433e-1	1	1.137433e-1	1.000000e+0	87	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002161	abnormal fertility/fecundity	90	1.345122e-1	1.000000e+0	1.000000e+0	7.434268e+0	1.345122e-1	1	1.345122e-1	1.000000e+0	91	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0011180	abnormal hematopoietic cell number	91	1.429801e-1	1.000000e+0	1.000000e+0	6.993980e+0	1.429801e-1	1	1.429801e-1	1.000000e+0	97	1.595825e-1	1.000000e+0	1.000000e+0	6.005659e+0	1.665096e-1	1	1502	5.000000e-1	6.657790e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002083	premature death	92	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	92	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0000716	abnormal immune system cell morphology	93	1.505458e-1	1.000000e+0	1.000000e+0	6.642496e+0	1.505458e-1	1	1.505458e-1	1.000000e+0	99	1.710276e-1	1.000000e+0	1.000000e+0	5.585449e+0	1.790366e-1	1	1615	5.000000e-1	6.191950e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0001392	abnormal locomotor behavior	94	1.510711e-1	1.000000e+0	1.000000e+0	6.619401e+0	1.510711e-1	1	1.510711e-1	1.000000e+0	90	1.309881e-1	1.000000e+0	1.000000e+0	7.375715e+0	1.355801e-1	1	1223	5.000000e-1	8.176615e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0001919	abnormal reproductive system physiology	95	1.530473e-1	1.000000e+0	1.000000e+0	6.533929e+0	1.530473e-1	1	1.530473e-1	1.000000e+0	96	1.495931e-1	1.000000e+0	1.000000e+0	6.424858e+0	1.556455e-1	1	1404	5.000000e-1	7.122507e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002163	abnormal gland morphology	96	1.548620e-1	1.000000e+0	1.000000e+0	6.457362e+0	1.548620e-1	1	1.548620e-1	1.000000e+0	95	1.460111e-1	1.000000e+0	1.000000e+0	6.589116e+0	1.517654e-1	1	1369	5.000000e-1	7.304602e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0003491	abnormal voluntary movement	97	1.639822e-1	1.000000e+0	1.000000e+0	6.098224e+0	1.639822e-1	1	1.639822e-1	1.000000e+0	93	1.399559e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	1310	5.000000e-1	7.633588e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0005379	endocrine/exocrine gland phenotype	98	1.670185e-1	1.000000e+0	1.000000e+0	5.987362e+0	1.670185e-1	1	1.670185e-1	1.000000e+0	98	1.601922e-1	1.000000e+0	1.000000e+0	5.981764e+0	1.671748e-1	1	1508	5.000000e-1	6.631300e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0005389	reproductive system phenotype	99	1.774158e-1	1.000000e+0	1.000000e+0	5.636476e+0	1.774158e-1	1	1.774158e-1	1.000000e+0	100	1.715322e-1	1.000000e+0	1.000000e+0	5.568210e+0	1.795909e-1	1	1620	5.000000e-1	6.172840e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002123	abnormal hematopoiesis	100	1.777183e-1	1.000000e+0	1.000000e+0	5.626882e+0	1.777183e-1	1	1.777183e-1	1.000000e+0	104	2.055841e-1	1.000000e+0	1.000000e+0	4.599949e+0	2.173937e-1	1	1961	5.000000e-1	5.099439e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002429	abnormal blood cell morphology/development	101	1.793335e-1	1.000000e+0	1.000000e+0	5.576203e+0	1.793335e-1	1	1.793335e-1	1.000000e+0	105	2.074604e-1	1.000000e+0	1.000000e+0	4.555808e+0	2.195000e-1	1	1980	5.000000e-1	5.050505e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0000685	abnormal immune system morphology	102	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	103	2.020229e-1	1.000000e+0	1.000000e+0	4.685974e+0	2.134028e-1	1	1925	5.000000e-1	5.194805e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002882	abnormal neuron morphology	103	1.824896e-1	1.000000e+0	1.000000e+0	5.479764e+0	1.824896e-1	1	1.824896e-1	1.000000e+0	94	1.439609e-1	1.000000e+0	1.000000e+0	6.686805e+0	1.495483e-1	1	1349	5.000000e-1	7.412898e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	104	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	107	2.274661e-1	1.000000e+0	1.000000e+0	4.130266e+0	2.421152e-1	1	2184	5.000000e-1	4.578755e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	105	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	108	2.333986e-1	1.000000e+0	1.000000e+0	4.018040e+0	2.488776e-1	1	2245	5.000000e-1	4.454343e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0009642	abnormal blood homeostasis	106	2.077260e-1	1.000000e+0	1.000000e+0	4.814034e+0	2.077260e-1	1	2.077260e-1	1.000000e+0	106	2.184756e-1	1.000000e+0	1.000000e+0	4.311902e+0	2.319162e-1	1	2092	5.000000e-1	4.780115e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0002066	abnormal motor capabilities/coordination/movement	107	2.177788e-1	1.000000e+0	1.000000e+0	4.591816e+0	2.177788e-1	1	2.177788e-1	1.000000e+0	102	1.858990e-1	1.000000e+0	1.000000e+0	5.116563e+0	1.954437e-1	1	1763	5.000000e-1	5.672150e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0003633	abnormal nervous system physiology	108	2.225344e-1	1.000000e+0	1.000000e+0	4.493687e+0	2.225344e-1	1	2.225344e-1	1.000000e+0	101	1.816925e-1	1.000000e+0	1.000000e+0	5.241429e+0	1.907877e-1	1	1721	5.000000e-1	5.810575e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0005387	immune system phenotype	109	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	111	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	110	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	109	2.350478e-1	1.000000e+0	1.000000e+0	3.987843e+0	2.507622e-1	1	2262	5.000000e-1	4.420866e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0004924	abnormal behavior	111	2.945352e-1	1.000000e+0	1.000000e+0	3.395180e+0	2.945352e-1	1	2.945352e-1	1.000000e+0	110	2.543172e-1	1.000000e+0	1.000000e+0	3.663891e+0	2.729339e-1	1	2462	5.000000e-1	4.061738e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0001764	abnormal homeostasis	112	2.990593e-1	1.000000e+0	1.000000e+0	3.343818e+0	2.990593e-1	1	2.990593e-1	1.000000e+0	113	3.044696e-1	1.000000e+0	1.000000e+0	3.011853e+0	3.320215e-1	1	2995	5.000000e-1	3.338898e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0005376	homeostasis/metabolism phenotype	113	3.389663e-1	1.000000e+0	1.000000e+0	2.950146e+0	3.389663e-1	1	3.389663e-1	1.000000e+0	114	3.467977e-1	1.000000e+0	1.000000e+0	2.607081e+0	3.835708e-1	1	3460	5.000000e-1	2.890173e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0003631	nervous system phenotype	114	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	112	2.844493e-1	1.000000e+0	1.000000e+0	3.244784e+0	3.081869e-1	1	2780	5.000000e-1	3.597122e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0010769	abnormal survival	115	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	115	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0010768	mortality/aging	116	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	116	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	SLC19A2
Mouse Phenotype	MP:0000001	mammalian phenotype	117	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	117	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	SLC19A2
Human Phenotype	HP:0004760	Congenital septal defect	1	4.190995e-5	2.575786e-1	2.575786e-1	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
Human Phenotype	HP:0004860	Thiamine-responsive megaloblastic anemia	1	4.190995e-5	2.575786e-1	2.575786e-1	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
Human Phenotype	HP:0001924	Sideroblastic anemia	3	2.724910e-4	1.000000e+0	5.582432e-1	3.669845e+3	2.724910e-4	1	2.724910e-4	1.000000e+0	3	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	SLC19A2
Human Phenotype	HP:0000548	Cone-rod dystrophy	4	5.472534e-4	1.000000e+0	8.408548e-1	1.827307e+3	5.472534e-4	1	5.472534e-4	1.000000e+0	4	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	SLC19A2
Human Phenotype	HP:0100651	Type I diabetes mellitus	5	1.506192e-3	1.000000e+0	1.000000e+0	6.639259e+2	1.506192e-3	1	1.506192e-3	1.000000e+0	6	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
Human Phenotype	HP:0001889	Megaloblastic anemia	6	2.215031e-3	1.000000e+0	1.000000e+0	4.514609e+2	2.215031e-3	1	2.215031e-3	1.000000e+0	5	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	SLC19A2
Human Phenotype	HP:0002637	Cerebral ischemia	7	2.236316e-3	1.000000e+0	1.000000e+0	4.471641e+2	2.236316e-3	1	2.236316e-3	1.000000e+0	8	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	SLC19A2
Human Phenotype	HP:0001297	Stroke	8	2.591234e-3	1.000000e+0	1.000000e+0	3.859165e+2	2.591234e-3	1	2.591234e-3	1.000000e+0	7	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	SLC19A2
Human Phenotype	HP:0009145	Abnormality of cerebral artery	9	3.077277e-3	1.000000e+0	1.000000e+0	3.249627e+2	3.077277e-3	1	3.077277e-3	1.000000e+0	12	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	SLC19A2
Human Phenotype	HP:0001972	Macrocytic anemia	10	3.459319e-3	1.000000e+0	1.000000e+0	2.890742e+2	3.459319e-3	1	3.459319e-3	1.000000e+0	9	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	SLC19A2
Human Phenotype	HP:0001696	Situs inversus totalis	11	3.849380e-3	1.000000e+0	1.000000e+0	2.597821e+2	3.849380e-3	1	3.849380e-3	1.000000e+0	15	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	SLC19A2
Human Phenotype	HP:0001609	Hoarse voice	12	3.873796e-3	1.000000e+0	1.000000e+0	2.581447e+2	3.873796e-3	1	3.873796e-3	1.000000e+0	10	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	SLC19A2
Human Phenotype	HP:0011534	Abnormal spatial orientation of the cardiac segments	13	3.969625e-3	1.000000e+0	1.000000e+0	2.519130e+2	3.969625e-3	1	3.969625e-3	1.000000e+0	16	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	SLC19A2
Human Phenotype	HP:0000556	Retinal dystrophy	14	4.437371e-3	1.000000e+0	1.000000e+0	2.253587e+2	4.437371e-3	1	4.437371e-3	1.000000e+0	14	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	SLC19A2
Human Phenotype	HP:0001651	Dextrocardia	15	4.497777e-3	1.000000e+0	1.000000e+0	2.223320e+2	4.497777e-3	1	4.497777e-3	1.000000e+0	19	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	SLC19A2
Human Phenotype	HP:0000546	Retinal degeneration	16	4.578161e-3	1.000000e+0	1.000000e+0	2.184283e+2	4.578161e-3	1	4.578161e-3	1.000000e+0	11	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	SLC19A2
Human Phenotype	HP:0004307	Abnormal anatomic location of the heart	17	4.647322e-3	1.000000e+0	1.000000e+0	2.151777e+2	4.647322e-3	1	4.647322e-3	1.000000e+0	20	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	SLC19A2
Human Phenotype	HP:0003363	Abdominal situs inversus	18	5.017624e-3	1.000000e+0	1.000000e+0	1.992975e+2	5.017624e-3	1	5.017624e-3	1.000000e+0	21	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	SLC19A2
Human Phenotype	HP:0010972	Anemia of inadequate production	19	5.774497e-3	1.000000e+0	1.000000e+0	1.731752e+2	5.774497e-3	1	5.774497e-3	1.000000e+0	23	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	SLC19A2
Human Phenotype	HP:0100545	Arterial stenosis	20	5.845884e-3	1.000000e+0	1.000000e+0	1.710605e+2	5.845884e-3	1	5.845884e-3	1.000000e+0	24	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	SLC19A2
Human Phenotype	HP:0001645	Sudden cardiac death	21	6.099072e-3	1.000000e+0	1.000000e+0	1.639594e+2	6.099072e-3	1	6.099072e-3	1.000000e+0	17	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	SLC19A2
Human Phenotype	HP:0001695	Cardiac arrest	22	6.130267e-3	1.000000e+0	1.000000e+0	1.631250e+2	6.130267e-3	1	6.130267e-3	1.000000e+0	18	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	SLC19A2
Human Phenotype	HP:0000572	Visual loss	23	6.223177e-3	1.000000e+0	1.000000e+0	1.606896e+2	6.223177e-3	1	6.223177e-3	1.000000e+0	22	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	SLC19A2
Human Phenotype	HP:0002020	Gastroesophageal reflux	24	6.299038e-3	1.000000e+0	1.000000e+0	1.587544e+2	6.299038e-3	1	6.299038e-3	1.000000e+0	12	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	SLC19A2
Human Phenotype	HP:0100659	Abnormality of the cerebral vasculature	25	8.176608e-3	1.000000e+0	1.000000e+0	1.223001e+2	8.176608e-3	1	8.176608e-3	1.000000e+0	27	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	SLC19A2
Human Phenotype	HP:0003355	Aminoaciduria	26	8.458357e-3	1.000000e+0	1.000000e+0	1.182263e+2	8.458357e-3	1	8.458357e-3	1.000000e+0	25	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	SLC19A2
Human Phenotype	HP:0001635	Congestive heart failure	27	9.050497e-3	1.000000e+0	1.000000e+0	1.104912e+2	9.050497e-3	1	9.050497e-3	1.000000e+0	26	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	SLC19A2
Human Phenotype	HP:0012072	Aciduria	28	1.017783e-2	1.000000e+0	1.000000e+0	9.825273e+1	1.017783e-2	1	1.017783e-2	1.000000e+0	28	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	SLC19A2
Human Phenotype	HP:0004337	Abnormality of amino acid metabolism	29	1.235776e-2	1.000000e+0	1.000000e+0	8.092080e+1	1.235776e-2	1	1.235776e-2	1.000000e+0	29	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	SLC19A2
Human Phenotype	HP:0001873	Thrombocytopenia	30	1.287046e-2	1.000000e+0	1.000000e+0	7.769728e+1	1.287046e-2	1	1.287046e-2	1.000000e+0	32	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	SLC19A2
Human Phenotype	HP:0011873	Abnormal platelet count	31	1.307528e-2	1.000000e+0	1.000000e+0	7.648017e+1	1.307528e-2	1	1.307528e-2	1.000000e+0	36	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	SLC19A2
Human Phenotype	HP:0004354	Abnormality of carboxylic acid metabolism	32	1.349326e-2	1.000000e+0	1.000000e+0	7.411106e+1	1.349326e-2	1	1.349326e-2	1.000000e+0	30	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	SLC19A2
Human Phenotype	HP:0001872	Abnormality of thrombocytes	33	1.595131e-2	1.000000e+0	1.000000e+0	6.269078e+1	1.595131e-2	1	1.595131e-2	1.000000e+0	41	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	SLC19A2
Human Phenotype	HP:0000819	Diabetes mellitus	34	1.619858e-2	1.000000e+0	1.000000e+0	6.173382e+1	1.619858e-2	1	1.619858e-2	1.000000e+0	39	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	SLC19A2
Human Phenotype	HP:0002577	Abnormality of the stomach	35	1.809177e-2	1.000000e+0	1.000000e+0	5.527375e+1	1.809177e-2	1	1.809177e-2	1.000000e+0	37	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	SLC19A2
Human Phenotype	HP:0011004	Abnormality of the systemic arterial tree	36	1.891919e-2	1.000000e+0	1.000000e+0	5.285638e+1	1.891919e-2	1	1.891919e-2	1.000000e+0	40	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	SLC19A2
Human Phenotype	HP:0007703	Abnormal retinal pigmentation	37	1.943895e-2	1.000000e+0	1.000000e+0	5.144311e+1	1.943895e-2	1	1.943895e-2	1.000000e+0	42	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	SLC19A2
Human Phenotype	HP:0001903	Anemia	38	1.958596e-2	1.000000e+0	1.000000e+0	5.105699e+1	1.958596e-2	1	1.958596e-2	1.000000e+0	51	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	SLC19A2
Human Phenotype	HP:0001638	Cardiomyopathy	39	2.024024e-2	1.000000e+0	1.000000e+0	4.940652e+1	2.024024e-2	1	2.024024e-2	1.000000e+0	49	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	SLC19A2
Human Phenotype	HP:0001631	Defect in the atrial septum	40	2.042369e-2	1.000000e+0	1.000000e+0	4.896274e+1	2.042369e-2	1	2.042369e-2	1.000000e+0	32	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	SLC19A2
Human Phenotype	HP:0001637	Abnormality of the myocardium	41	2.048425e-2	1.000000e+0	1.000000e+0	4.881799e+1	2.048425e-2	1	2.048425e-2	1.000000e+0	50	2.741405e-2	1.000000e+0	1.000000e+0	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	SLC19A2
Human Phenotype	HP:0005120	Abnormality of cardiac atrium	42	2.064140e-2	1.000000e+0	1.000000e+0	4.844632e+1	2.064140e-2	1	2.064140e-2	1.000000e+0	35	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	SLC19A2
Human Phenotype	HP:0001629	Ventricular septal defect	43	2.091358e-2	1.000000e+0	1.000000e+0	4.781582e+1	2.091358e-2	1	2.091358e-2	1.000000e+0	31	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	SLC19A2
Human Phenotype	HP:0010438	Abnormality of the ventricular septum	44	2.136910e-2	1.000000e+0	1.000000e+0	4.679655e+1	2.136910e-2	1	2.136910e-2	1.000000e+0	32	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	SLC19A2
Human Phenotype	HP:0008051	Abnormality of the retinal pigment epithelium	45	2.142508e-2	1.000000e+0	1.000000e+0	4.667427e+1	2.142508e-2	1	2.142508e-2	1.000000e+0	45	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	SLC19A2
Human Phenotype	HP:0001608	Abnormality of the voice	46	2.156663e-2	1.000000e+0	1.000000e+0	4.636794e+1	2.156663e-2	1	2.156663e-2	1.000000e+0	38	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	SLC19A2
Human Phenotype	HP:0011675	Arrhythmia	47	2.164317e-2	1.000000e+0	1.000000e+0	4.620396e+1	2.164317e-2	1	2.164317e-2	1.000000e+0	44	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	SLC19A2
Human Phenotype	HP:0001877	Abnormality of erythrocytes	48	2.240890e-2	1.000000e+0	1.000000e+0	4.462513e+1	2.240890e-2	1	2.240890e-2	1.000000e+0	53	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	SLC19A2
Human Phenotype	HP:0003110	Abnormality of urine homeostasis	49	2.316703e-2	1.000000e+0	1.000000e+0	4.316480e+1	2.316703e-2	1	2.316703e-2	1.000000e+0	52	3.090952e-2	1.000000e+0	1.000000e+0	3.210142e+1	3.115127e-2	1	281	5.000000e-1	3.558719e-3	unnamed	SLC19A2
Human Phenotype	HP:0011014	Abnormal glucose homeostasis	50	2.584232e-2	1.000000e+0	1.000000e+0	3.869621e+1	2.584232e-2	1	2.584232e-2	1.000000e+0	55	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	SLC19A2
Human Phenotype	HP:0001251	Ataxia	51	2.648195e-2	1.000000e+0	1.000000e+0	3.776157e+1	2.648195e-2	1	2.648195e-2	1.000000e+0	54	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	SLC19A2
Human Phenotype	HP:0001713	Abnormality of cardiac ventricle	52	2.770630e-2	1.000000e+0	1.000000e+0	3.609287e+1	2.770630e-2	1	2.770630e-2	1.000000e+0	43	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	SLC19A2
Human Phenotype	HP:0002031	Abnormality of the esophagus	53	2.788607e-2	1.000000e+0	1.000000e+0	3.586019e+1	2.788607e-2	1	2.788607e-2	1.000000e+0	47	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	SLC19A2
Human Phenotype	HP:0001600	Abnormality of the larynx	54	2.804911e-2	1.000000e+0	1.000000e+0	3.565176e+1	2.804911e-2	1	2.804911e-2	1.000000e+0	46	2.402182e-2	1.000000e+0	1.000000e+0	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	SLC19A2
Human Phenotype	HP:0011013	Abnormality of carbohydrate metabolism/homeostasis	55	2.907742e-2	1.000000e+0	1.000000e+0	3.439095e+1	2.907742e-2	1	2.907742e-2	1.000000e+0	59	3.799030e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	346	5.000000e-1	2.890173e-3	unnamed	SLC19A2
Human Phenotype	HP:0000648	Optic atrophy	56	2.952567e-2	1.000000e+0	1.000000e+0	3.386883e+1	2.952567e-2	1	2.952567e-2	1.000000e+0	56	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	SLC19A2
Human Phenotype	HP:0001671	Abnormality of the cardiac septa	57	3.031987e-2	1.000000e+0	1.000000e+0	3.298167e+1	3.031987e-2	1	3.031987e-2	1.000000e+0	48	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	SLC19A2
Human Phenotype	HP:0000587	Abnormality of the optic nerve	58	3.320424e-2	1.000000e+0	1.000000e+0	3.011663e+1	3.320424e-2	1	3.320424e-2	1.000000e+0	60	3.896867e-2	1.000000e+0	1.000000e+0	2.540986e+1	3.935480e-2	1	355	5.000000e-1	2.816901e-3	unnamed	SLC19A2
Human Phenotype	HP:0002087	Abnormality of the upper respiratory tract	59	3.607184e-2	1.000000e+0	1.000000e+0	2.772246e+1	3.607184e-2	1	3.607184e-2	1.000000e+0	57	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	SLC19A2
Human Phenotype	HP:0011277	Abnormality of the urinary system physiology	60	3.851912e-2	1.000000e+0	1.000000e+0	2.596113e+1	3.851912e-2	1	3.851912e-2	1.000000e+0	62	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	SLC19A2
Human Phenotype	HP:0011443	Abnormality of coordination	61	4.159660e-2	1.000000e+0	1.000000e+0	2.404043e+1	4.159660e-2	1	4.159660e-2	1.000000e+0	61	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	SLC19A2
Human Phenotype	HP:0000479	Abnormality of the retina	62	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	66	4.829244e-2	1.000000e+0	1.000000e+0	2.045465e+1	4.888864e-2	1	441	5.000000e-1	2.267574e-3	unnamed	SLC19A2
Human Phenotype	HP:0000028	Cryptorchidism	63	4.205640e-2	1.000000e+0	1.000000e+0	2.377759e+1	4.205640e-2	1	4.205640e-2	1.000000e+0	58	3.461655e-2	1.000000e+0	1.000000e+0	2.863651e+1	3.492046e-2	1	315	5.000000e-1	3.174603e-3	unnamed	SLC19A2
Human Phenotype	HP:0002597	Abnormality of the vasculature	64	4.289777e-2	1.000000e+0	1.000000e+0	2.331124e+1	4.289777e-2	1	4.289777e-2	1.000000e+0	71	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	SLC19A2
Human Phenotype	HP:0000505	Visual impairment	65	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	67	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	SLC19A2
Human Phenotype	HP:0011025	Abnormality of cardiovascular system physiology	66	4.649297e-2	1.000000e+0	1.000000e+0	2.150863e+1	4.649297e-2	1	4.649297e-2	1.000000e+0	69	4.958982e-2	1.000000e+0	1.000000e+0	1.991280e+1	5.021895e-2	1	453	5.000000e-1	2.207506e-3	unnamed	SLC19A2
Human Phenotype	HP:0000407	Sensorineural hearing impairment	67	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	64	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	SLC19A2
Human Phenotype	HP:0001317	Abnormality of the cerebellum	68	4.894940e-2	1.000000e+0	1.000000e+0	2.042926e+1	4.894940e-2	1	4.894940e-2	1.000000e+0	76	5.423149e-2	1.000000e+0	1.000000e+0	1.818649e+1	5.498587e-2	1	496	5.000000e-1	2.016129e-3	unnamed	SLC19A2
Human Phenotype	HP:0000504	Abnormality of vision	69	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	75	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	SLC19A2
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	70	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	68	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	SLC19A2
Human Phenotype	HP:0000359	Abnormality of the inner ear	71	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	70	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	SLC19A2
Human Phenotype	HP:0000035	Abnormality of the testis	72	5.101368e-2	1.000000e+0	1.000000e+0	1.960258e+1	5.101368e-2	1	5.101368e-2	1.000000e+0	63	4.645297e-2	1.000000e+0	1.000000e+0	2.127476e+1	4.700405e-2	1	424	5.000000e-1	2.358491e-3	unnamed	SLC19A2
Human Phenotype	HP:0000639	Nystagmus	73	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	73	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	SLC19A2
Human Phenotype	HP:0000022	Abnormality of male internal genitalia	74	5.264829e-2	1.000000e+0	1.000000e+0	1.899397e+1	5.264829e-2	1	5.264829e-2	1.000000e+0	65	4.775160e-2	1.000000e+0	1.000000e+0	2.068922e+1	4.833435e-2	1	436	5.000000e-1	2.293578e-3	unnamed	SLC19A2
Human Phenotype	HP:0001263	Global developmental delay	75	5.775253e-2	1.000000e+0	1.000000e+0	1.731526e+1	5.775253e-2	1	5.775253e-2	1.000000e+0	82	6.390983e-2	1.000000e+0	1.000000e+0	1.539334e+1	6.496314e-2	1	586	5.000000e-1	1.706485e-3	unnamed	SLC19A2
Human Phenotype	HP:0000496	Abnormality of eye movement	76	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	79	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	SLC19A2
Human Phenotype	HP:0000818	Abnormality of the endocrine system	77	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	81	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	SLC19A2
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	78	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	93	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	SLC19A2
Human Phenotype	HP:0000032	Abnormality of male external genitalia	79	5.856997e-2	1.000000e+0	1.000000e+0	1.707359e+1	5.856997e-2	1	5.856997e-2	1.000000e+0	72	5.207398e-2	1.000000e+0	1.000000e+0	1.895063e+1	5.276869e-2	1	476	5.000000e-1	2.100840e-3	unnamed	SLC19A2
Human Phenotype	HP:0001098	Abnormality of the fundus	80	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	83	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	SLC19A2
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	81	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	84	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	SLC19A2
Human Phenotype	HP:0000811	Abnormal external genitalia	82	5.948677e-2	1.000000e+0	1.000000e+0	1.681046e+1	5.948677e-2	1	5.948677e-2	1.000000e+0	74	5.336878e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	488	5.000000e-1	2.049180e-3	unnamed	SLC19A2
Human Phenotype	HP:0010461	Abnormality of the male genitalia	83	6.153041e-2	1.000000e+0	1.000000e+0	1.625213e+1	6.153041e-2	1	6.153041e-2	1.000000e+0	77	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	SLC19A2
Human Phenotype	HP:0004322	Short stature	84	6.307451e-2	1.000000e+0	1.000000e+0	1.585427e+1	6.307451e-2	1	6.307451e-2	1.000000e+0	80	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	SLC19A2
Human Phenotype	HP:0000812	Abnormal internal genitalia	85	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	78	6.068925e-2	1.000000e+0	1.000000e+0	1.622392e+1	6.163738e-2	1	556	5.000000e-1	1.798561e-3	unnamed	SLC19A2
Human Phenotype	HP:0011024	Abnormality of the gastrointestinal tract	86	6.745114e-2	1.000000e+0	1.000000e+0	1.482555e+1	6.745114e-2	1	6.745114e-2	1.000000e+0	85	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	SLC19A2
Human Phenotype	HP:0000002	Abnormality of body height	87	6.858327e-2	1.000000e+0	1.000000e+0	1.458081e+1	6.858327e-2	1	6.858327e-2	1.000000e+0	86	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	SLC19A2
Human Phenotype	HP:0002564	Malformation of the heart and great vessels	88	7.308175e-2	1.000000e+0	1.000000e+0	1.368331e+1	7.308175e-2	1	7.308175e-2	1.000000e+0	88	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	SLC19A2
Human Phenotype	HP:0012243	Abnormal genital system morphology	89	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	87	6.712488e-2	1.000000e+0	1.000000e+0	1.464367e+1	6.828890e-2	1	616	5.000000e-1	1.623377e-3	unnamed	SLC19A2
Human Phenotype	HP:0000365	Hearing impairment	90	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	90	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	SLC19A2
Human Phenotype	HP:0001627	Abnormality of the heart	91	7.369587e-2	1.000000e+0	1.000000e+0	1.356928e+1	7.369587e-2	1	7.369587e-2	1.000000e+0	89	7.129618e-2	1.000000e+0	1.000000e+0	1.377176e+1	7.261238e-2	1	655	5.000000e-1	1.526718e-3	unnamed	SLC19A2
Human Phenotype	HP:0000364	Hearing abnormality	92	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	91	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	SLC19A2
Human Phenotype	HP:0001510	Growth delay	93	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	94	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	SLC19A2
Human Phenotype	HP:0000078	Abnormality of the genital system	94	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	92	7.513832e-2	1.000000e+0	1.000000e+0	1.305427e+1	7.660329e-2	1	691	5.000000e-1	1.447178e-3	unnamed	SLC19A2
Human Phenotype	HP:0001250	Seizures	95	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	95	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	SLC19A2
Human Phenotype	HP:0011442	Abnormality of central motor function	96	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	97	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	SLC19A2
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	97	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	96	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	SLC19A2
Human Phenotype	HP:0002086	Abnormality of the respiratory system	98	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	99	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	SLC19A2
Human Phenotype	HP:0000079	Abnormality of the urinary system	99	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	98	9.053295e-2	1.000000e+0	1.000000e+0	1.079007e+1	9.267779e-2	1	836	5.000000e-1	1.196172e-3	unnamed	SLC19A2
Human Phenotype	HP:0012443	Abnormality of the brain	100	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	100	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	SLC19A2
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	101	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	101	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	SLC19A2
Human Phenotype	HP:0000951	Abnormality of the skin	102	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	103	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	SLC19A2
Human Phenotype	HP:0000598	Abnormality of the ear	103	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	102	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	SLC19A2
Human Phenotype	HP:0012373	Abnormal eye physiology	104	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	105	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	SLC19A2
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	105	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	104	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	SLC19A2
Human Phenotype	HP:0012374	Abnormality of the globe	106	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	106	1.140610e-1	1.000000e+0	1.000000e+0	8.509906e+0	1.175101e-1	1	1060	5.000000e-1	9.433962e-4	unnamed	SLC19A2
Human Phenotype	HP:0012372	Abnormal eye morphology	107	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	108	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	SLC19A2
Human Phenotype	HP:0001507	Growth abnormality	108	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	107	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	SLC19A2
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	109	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	109	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	SLC19A2
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	110	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	114	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	SLC19A2
Human Phenotype	HP:0001438	Abnormality of the abdomen	111	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	111	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	SLC19A2
Human Phenotype	HP:0001574	Abnormality of the integument	112	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	110	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	SLC19A2
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	113	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	112	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	SLC19A2
Human Phenotype	HP:0100543	Cognitive impairment	114	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	113	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	SLC19A2
Human Phenotype	HP:0000007	Autosomal recessive inheritance	115	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	117	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	SLC19A2
Human Phenotype	HP:0000478	Abnormality of the eye	116	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	115	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	SLC19A2
Human Phenotype	HP:0011446	Abnormality of higher mental function	117	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	116	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	SLC19A2
Human Phenotype	HP:0002011	Abnormality of the central nervous system	118	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	118	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	SLC19A2
Human Phenotype	HP:0000707	Abnormality of the nervous system	119	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	119	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	SLC19A2
Human Phenotype	HP:0000005	Mode of inheritance	120	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	120	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	SLC19A2
Human Phenotype	HP:0000118	Phenotypic abnormality	121	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	121	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	SLC19A2
Human Phenotype	HP:0000001	All	122	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	122	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	SLC19A2
Disease Ontology	DOID:10915	Wernicke-Korsakoff syndrome	1	4.190995e-5	9.366874e-2	9.366874e-2	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	1	1.108586e-4	2.477690e-1	2.477690e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
Disease Ontology	DOID:13382	megaloblastic anemia	2	2.562795e-4	5.727847e-1	2.863923e-1	3.901991e+3	2.562795e-4	1	2.562795e-4	1.000000e+0	2	4.433975e-4	9.909934e-1	4.954967e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	SLC19A2
Disease Ontology	DOID:5113	nutritional deficiency disease	3	1.563754e-3	1.000000e+0	1.000000e+0	6.394868e+2	1.563754e-3	1	1.563754e-3	1.000000e+0	3	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	SLC19A2
Disease Ontology	DOID:2355	anemia	4	1.971202e-2	1.000000e+0	1.000000e+0	5.073048e+1	1.971202e-2	1	1.971202e-2	1.000000e+0	4	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	SLC19A2
Disease Ontology	DOID:9973	substance dependence	5	3.222615e-2	1.000000e+0	1.000000e+0	3.103070e+1	3.222615e-2	1	3.222615e-2	1.000000e+0	5	2.883484e-2	1.000000e+0	1.000000e+0	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	SLC19A2
Disease Ontology	DOID:303	substance-related disease	6	3.398230e-2	1.000000e+0	1.000000e+0	2.942708e+1	3.398230e-2	1	3.398230e-2	1.000000e+0	6	3.123689e-2	1.000000e+0	1.000000e+0	3.176232e+1	3.148384e-2	1	284	5.000000e-1	3.521127e-3	unnamed	SLC19A2
Disease Ontology	DOID:374	nutrition disease	7	3.940307e-2	1.000000e+0	1.000000e+0	2.537873e+1	3.940307e-2	1	3.940307e-2	1.000000e+0	7	4.027239e-2	1.000000e+0	1.000000e+0	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	SLC19A2
Disease Ontology	DOID:0014667	disease of metabolism	8	1.387898e-1	1.000000e+0	1.000000e+0	7.205143e+0	1.387898e-1	1	1.387898e-1	1.000000e+0	8	1.487750e-1	1.000000e+0	1.000000e+0	6.461676e+0	1.547586e-1	1	1396	5.000000e-1	7.163324e-4	unnamed	SLC19A2
Disease Ontology	DOID:74	hematopoietic system disease	9	1.634383e-1	1.000000e+0	1.000000e+0	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	10	1.726418e-1	1.000000e+0	1.000000e+0	5.530656e+0	1.808104e-1	1	1631	5.000000e-1	6.131208e-4	unnamed	SLC19A2
Disease Ontology	DOID:150	disease of mental health	10	1.737444e-1	1.000000e+0	1.000000e+0	5.755580e+0	1.737444e-1	1	1.737444e-1	1.000000e+0	9	1.522491e-1	1.000000e+0	1.000000e+0	6.308042e+0	1.585278e-1	1	1430	5.000000e-1	6.993007e-4	unnamed	SLC19A2
Disease Ontology	DOID:225	syndrome	11	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	11	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	SLC19A2
Disease Ontology	DOID:1287	cardiovascular system disease	12	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	12	2.586189e-1	1.000000e+0	1.000000e+0	3.598125e+0	2.779225e-1	1	2507	5.000000e-1	3.988831e-4	unnamed	SLC19A2
Disease Ontology	DOID:2985	chronic rejection of renal transplant	13	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	13	2.866046e-1	1.000000e+0	1.000000e+0	3.218159e+0	3.107367e-1	1	2803	5.000000e-1	3.567606e-4	unnamed	SLC19A2
Disease Ontology	DOID:2108	transplant-related disease	14	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	14	2.866982e-1	1.000000e+0	1.000000e+0	3.217011e+0	3.108475e-1	1	2804	5.000000e-1	3.566334e-4	unnamed	SLC19A2
Disease Ontology	DOID:557	kidney disease	15	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	15	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	SLC19A2
Disease Ontology	DOID:18	urinary system disease	16	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	16	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	SLC19A2
Disease Ontology	DOID:2914	immune system disease	17	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	17	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	SLC19A2
Disease Ontology	DOID:7	disease of anatomical entity	18	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	18	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	SLC19A2
Disease Ontology	DOID:4	disease	19	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	19	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	SLC19A2
MSigDB Pathway	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	Genes involved in Metabolism of vitamins and cofactors	1	4.559091e-3	1.000000e+0	1.000000e+0	2.193420e+2	4.559091e-3	1	4.559091e-3	1.000000e+0	1	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	SLC19A2
MGI Expression: Detected	11130	TS23_3rd ventricle	1	2.567765e-3	1.000000e+0	1.000000e+0	3.894437e+2	2.567765e-3	1	2.567765e-3	1.000000e+0	1	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	CCDC181
MGI Expression: Detected	9959	TS23_4th ventricle	2	1.442165e-2	1.000000e+0	1.000000e+0	6.934018e+1	1.442165e-2	1	1.442165e-2	1.000000e+0	2	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	CCDC181
MGI Expression: Detected	11304	TS23_choroid invagination	3	3.027258e-2	1.000000e+0	1.000000e+0	3.303319e+1	3.027258e-2	1	3.027258e-2	1.000000e+0	3	3.090952e-2	1.000000e+0	1.000000e+0	3.210142e+1	3.115127e-2	1	281	5.000000e-1	3.558719e-3	unnamed	CCDC181
MGI Expression: Detected	116	TS10_embryo	4	7.866411e-2	1.000000e+0	1.000000e+0	1.271228e+1	7.866411e-2	1	7.866411e-2	1.000000e+0	4	7.556473e-2	1.000000e+0	1.000000e+0	1.297914e+1	7.704673e-2	1	695	5.000000e-1	1.438849e-3	unnamed	SLC19A2
MGI Expression: Detected	115	Theiler_stage_10	5	8.203126e-2	1.000000e+0	1.000000e+0	1.219048e+1	8.203126e-2	1	8.203126e-2	1.000000e+0	5	7.929164e-2	1.000000e+0	1.000000e+0	1.235685e+1	8.092678e-2	1	730	5.000000e-1	1.369863e-3	unnamed	SLC19A2
MGI Expression: Detected	7125	TS28_skeletal muscle	6	1.519191e-1	1.000000e+0	1.000000e+0	6.582450e+0	1.519191e-1	1	1.519191e-1	1.000000e+0	6	1.554104e-1	1.000000e+0	1.000000e+0	6.174196e+0	1.619644e-1	1	1461	5.000000e-1	6.844627e-4	unnamed	SLC19A2
MGI Expression: Detected	2654	TS18_embryo	7	1.821313e-1	1.000000e+0	1.000000e+0	5.490544e+0	1.821313e-1	1	1.821313e-1	1.000000e+0	7	1.620199e-1	1.000000e+0	1.000000e+0	5.911206e+0	1.691702e-1	1	1526	5.000000e-1	6.553080e-4	unnamed	SLC19A2
MGI Expression: Detected	2653	Theiler_stage_18	8	1.826749e-1	1.000000e+0	1.000000e+0	5.474206e+0	1.826749e-1	1	1.826749e-1	1.000000e+0	8	1.627301e-1	1.000000e+0	1.000000e+0	5.884214e+0	1.699462e-1	1	1533	5.000000e-1	6.523157e-4	unnamed	SLC19A2
MGI Expression: Detected	7038	TS28_spleen	9	1.850698e-1	1.000000e+0	1.000000e+0	5.403366e+0	1.850698e-1	1	1.850698e-1	1.000000e+0	10	1.970636e-1	1.000000e+0	1.000000e+0	4.810933e+0	2.078599e-1	1	1875	5.000000e-1	5.333333e-4	unnamed	SLC19A2
MGI Expression: Detected	7123	TS28_muscle	10	1.884267e-1	1.000000e+0	1.000000e+0	5.307102e+0	1.884267e-1	1	1.884267e-1	1.000000e+0	9	1.924875e-1	1.000000e+0	1.000000e+0	4.931930e+0	2.027604e-1	1	1829	5.000000e-1	5.467469e-4	unnamed	SLC19A2
MGI Expression: Detected	6963	TS28_liver	11	2.213497e-1	1.000000e+0	1.000000e+0	4.517739e+0	2.213497e-1	1	2.213497e-1	1.000000e+0	19	2.458689e-1	1.000000e+0	1.000000e+0	3.799705e+0	2.631783e-1	1	2374	5.000000e-1	4.212300e-4	unnamed	SLC19A2
MGI Expression: Detected	7036	TS28_haemolymphoid system	12	2.241684e-1	1.000000e+0	1.000000e+0	4.460933e+0	2.241684e-1	1	2.241684e-1	1.000000e+0	17	2.393082e-1	1.000000e+0	1.000000e+0	3.911752e+0	2.556399e-1	1	2306	5.000000e-1	4.336513e-4	unnamed	SLC19A2
MGI Expression: Detected	6962	TS28_liver and biliary system	13	2.293478e-1	1.000000e+0	1.000000e+0	4.360190e+0	2.293478e-1	1	2.293478e-1	1.000000e+0	23	2.531680e-1	1.000000e+0	1.000000e+0	3.681837e+0	2.716036e-1	1	2450	5.000000e-1	4.081633e-4	unnamed	SLC19A2
MGI Expression: Detected	6948	TS28_lung	14	2.297513e-1	1.000000e+0	1.000000e+0	4.352532e+0	2.297513e-1	1	2.297513e-1	1.000000e+0	13	2.341749e-1	1.000000e+0	1.000000e+0	4.003773e+0	2.497644e-1	1	2253	5.000000e-1	4.438526e-4	unnamed	SLC19A2
MGI Expression: Detected	6946	TS28_respiratory system	15	2.309063e-1	1.000000e+0	1.000000e+0	4.330761e+0	2.309063e-1	1	2.309063e-1	1.000000e+0	16	2.354356e-1	1.000000e+0	1.000000e+0	3.980803e+0	2.512056e-1	1	2266	5.000000e-1	4.413063e-4	unnamed	SLC19A2
MGI Expression: Detected	6952	TS28_testis	16	2.313330e-1	1.000000e+0	1.000000e+0	4.322774e+0	2.313330e-1	1	2.313330e-1	1.000000e+0	18	2.397915e-1	1.000000e+0	1.000000e+0	3.903289e+0	2.561942e-1	1	2311	5.000000e-1	4.327131e-4	unnamed	SLC19A2
MGI Expression: Detected	6951	TS28_male reproductive system	17	2.379727e-1	1.000000e+0	1.000000e+0	4.202163e+0	2.379727e-1	1	2.379727e-1	1.000000e+0	21	2.476009e-1	1.000000e+0	1.000000e+0	3.771112e+0	2.651738e-1	1	2392	5.000000e-1	4.180602e-4	unnamed	SLC19A2
MGI Expression: Detected	7103	TS28_heart	18	2.471289e-1	1.000000e+0	1.000000e+0	4.046471e+0	2.471289e-1	1	2.471289e-1	1.000000e+0	20	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	SLC19A2
MGI Expression: Detected	6931	TS25_embryo	19	2.493552e-1	1.000000e+0	1.000000e+0	4.010344e+0	2.493552e-1	1	2.493552e-1	1.000000e+0	11	2.315532e-1	1.000000e+0	1.000000e+0	4.052336e+0	2.467712e-1	1	2226	5.000000e-1	4.492363e-4	unnamed	SLC19A2
MGI Expression: Detected	6930	Theiler_stage_25	20	2.502634e-1	1.000000e+0	1.000000e+0	3.995791e+0	2.502634e-1	1	2.502634e-1	1.000000e+0	12	2.329132e-1	1.000000e+0	1.000000e+0	4.027009e+0	2.483233e-1	1	2240	5.000000e-1	4.464286e-4	unnamed	SLC19A2
MGI Expression: Detected	6960	TS28_kidney	21	2.525264e-1	1.000000e+0	1.000000e+0	3.959982e+0	2.525264e-1	1	2.525264e-1	1.000000e+0	24	2.607175e-1	1.000000e+0	1.000000e+0	3.566825e+0	2.803614e-1	1	2529	5.000000e-1	3.954132e-4	unnamed	SLC19A2
MGI Expression: Detected	7098	TS28_cardiovascular system	22	2.541249e-1	1.000000e+0	1.000000e+0	3.935073e+0	2.541249e-1	1	2.541249e-1	1.000000e+0	22	2.524013e-1	1.000000e+0	1.000000e+0	3.693898e+0	2.707167e-1	1	2442	5.000000e-1	4.095004e-4	unnamed	SLC19A2
MGI Expression: Detected	6959	TS28_renal-urinary system	23	2.619747e-1	1.000000e+0	1.000000e+0	3.817163e+0	2.619747e-1	1	2.619747e-1	1.000000e+0	25	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	SLC19A2
MGI Expression: Detected	6950	TS28_reproductive system	24	3.370939e-1	1.000000e+0	1.000000e+0	2.966533e+0	3.370939e-1	1	3.370939e-1	1.000000e+0	30	3.615866e-1	1.000000e+0	1.000000e+0	2.487728e+0	4.019733e-1	1	3626	5.000000e-1	2.757860e-4	unnamed	SLC19A2
MGI Expression: Detected	9951	TS23_diencephalon	25	3.573514e-1	1.000000e+0	1.000000e+0	2.798366e+0	3.573514e-1	1	3.573514e-1	1.000000e+0	26	2.791881e-1	1.000000e+0	1.000000e+0	3.311490e+0	3.019788e-1	1	2724	5.000000e-1	3.671072e-4	unnamed	CCDC181
MGI Expression: Detected	8824	TS23_hindbrain	26	3.841897e-1	1.000000e+0	1.000000e+0	2.602881e+0	3.841897e-1	1	3.841897e-1	1.000000e+0	27	3.099139e-1	1.000000e+0	1.000000e+0	2.953667e+0	3.385622e-1	1	3054	5.000000e-1	3.274394e-4	unnamed	CCDC181
MGI Expression: Detected	9955	TS23_telencephalon	27	3.981348e-1	1.000000e+0	1.000000e+0	2.511712e+0	3.981348e-1	1	3.981348e-1	1.000000e+0	28	3.219255e-1	1.000000e+0	1.000000e+0	2.832182e+0	3.530846e-1	1	3185	5.000000e-1	3.139717e-4	unnamed	CCDC181
MGI Expression: Detected	6945	TS28_visceral organ	28	4.216843e-1	1.000000e+0	1.000000e+0	2.371443e+0	4.216843e-1	1	4.216843e-1	1.000000e+0	32	4.474230e-1	1.000000e+0	1.000000e+0	1.948272e+0	5.132753e-1	1	4630	5.000000e-1	2.159827e-4	unnamed	SLC19A2
MGI Expression: Detected	8820	TS23_forebrain	29	4.358269e-1	1.000000e+0	1.000000e+0	2.294489e+0	4.358269e-1	1	4.358269e-1	1.000000e+0	29	3.510021e-1	1.000000e+0	1.000000e+0	2.572141e+0	3.887811e-1	1	3507	5.000000e-1	2.851440e-4	unnamed	CCDC181
MGI Expression: Detected	7005	TS28_brain	30	4.776274e-1	1.000000e+0	1.000000e+0	2.093682e+0	4.776274e-1	1	4.776274e-1	1.000000e+0	33	4.562057e-1	1.000000e+0	1.000000e+0	1.904264e+0	5.251372e-1	1	4737	5.000000e-1	2.111041e-4	unnamed	SLC19A2
MGI Expression: Detected	7003	TS28_central nervous system	31	4.961740e-1	1.000000e+0	1.000000e+0	2.015422e+0	4.961740e-1	1	4.961740e-1	1.000000e+0	36	4.783750e-1	1.000000e+0	1.000000e+0	1.800140e+0	5.555124e-1	1	5011	5.000000e-1	1.995610e-4	unnamed	SLC19A2
MGI Expression: Detected	7001	TS28_nervous system	32	4.974351e-1	1.000000e+0	1.000000e+0	2.010313e+0	4.974351e-1	1	4.974351e-1	1.000000e+0	37	4.798952e-1	1.000000e+0	1.000000e+0	1.793340e+0	5.576188e-1	1	5030	5.000000e-1	1.988072e-4	unnamed	SLC19A2
MGI Expression: Detected	7901	TS23_brain	33	5.025340e-1	1.000000e+0	1.000000e+0	1.989915e+0	5.025340e-1	1	5.025340e-1	1.000000e+0	31	4.293954e-1	1.000000e+0	1.000000e+0	2.044074e+0	4.892190e-1	1	4413	5.000000e-1	2.266032e-4	unnamed	CCDC181
MGI Expression: Detected	7608	TS23_central nervous system	34	5.265571e-1	1.000000e+0	1.000000e+0	1.899129e+0	5.265571e-1	1	5.265571e-1	1.000000e+0	34	4.610183e-1	1.000000e+0	1.000000e+0	1.880838e+0	5.316778e-1	1	4796	5.000000e-1	2.085071e-4	unnamed	CCDC181
MGI Expression: Detected	7501	TS23_nervous system	35	5.331601e-1	1.000000e+0	1.000000e+0	1.875609e+0	5.331601e-1	1	5.331601e-1	1.000000e+0	35	4.686418e-1	1.000000e+0	1.000000e+0	1.844683e+0	5.420986e-1	1	4890	5.000000e-1	2.044990e-4	unnamed	CCDC181
MGI Expression: Detected	6944	TS28_organ system	36	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	38	6.326325e-1	1.000000e+0	1.000000e+0	1.269420e+0	7.877612e-1	1	7106	5.000000e-1	1.407261e-4	unnamed	SLC19A2
MGI Expression: Detected	6937	TS28_postnatal mouse	37	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	39	6.373878e-1	1.000000e+0	1.000000e+0	1.256862e+0	7.956322e-1	1	7177	5.000000e-1	1.393340e-4	unnamed	SLC19A2
MGI Expression: Detected	7445	TS23_organ system	38	6.921258e-1	1.000000e+0	1.000000e+0	1.444824e+0	6.921258e-1	1	6.921258e-1	1.000000e+0	40	6.938167e-1	1.000000e+0	1.000000e+0	1.119447e+0	8.932986e-1	1	8058	5.000000e-1	1.241003e-4	unnamed	CCDC181
MGI Expression: Detected	6925	TS23_embryo	39	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	14	2.342505e-1	1.000000e+0	1.000000e+0	2.066079e+0	9.680173e-1	2	8732	1.000000e+0	2.290426e-4	unnamed	CCDC181,SLC19A2
MGI Expression: Detected	6924	Theiler_stage_23	40	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	15	2.344115e-1	1.000000e+0	1.000000e+0	2.065369e+0	9.683499e-1	2	8735	1.000000e+0	2.289639e-4	unnamed	CCDC181,SLC19A2
MSigDB Perturbation	MATZUK_SPERMATOGONIA	Genes important for spermatogonia, based on mouse models with male reproductive defects.	1	2.711030e-3	1.000000e+0	1.000000e+0	3.688635e+2	2.711030e-3	1	2.711030e-3	1.000000e+0	2	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	SLC19A2
MSigDB Perturbation	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	Genes down-regulated in CT60/4 cells (breast cancer reverted to normal by transfer of chromosome 8p region) vs parental MDA-MB-231 cells (deleted chromosome 8p).	2	3.253237e-3	1.000000e+0	1.000000e+0	3.073861e+2	3.253237e-3	1	3.253237e-3	1.000000e+0	4	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	SLC19A2
MSigDB Perturbation	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	Genes with high levels of histone H3 monomethylation mark at K27 (H3K27me1) in SW48 cells (colon cancer) by ChIP-chip assay on a 12K CpG array (CpG promoters only, HCP=high-CpG-density promoters).	3	4.344359e-3	1.000000e+0	1.000000e+0	2.301836e+2	4.344359e-3	1	4.344359e-3	1.000000e+0	3	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	CCDC181
MSigDB Perturbation	ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	Genes up-regulated in K562 cells (lymphoblast) by MYC [GeneID=4609] in the presence of PSMD9 [GeneID=5715].	4	5.619655e-3	1.000000e+0	1.000000e+0	1.779469e+2	5.619655e-3	1	5.619655e-3	1.000000e+0	6	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	SLC19A2
MSigDB Perturbation	ZHANG_TLX_TARGETS_DN	Genes down-regulated in neural stem cells (NSC) at both 36 h and 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	5	9.917184e-3	1.000000e+0	1.000000e+0	1.008351e+2	9.917184e-3	1	9.917184e-3	1.000000e+0	9	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	SLC19A2
MSigDB Perturbation	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	Genes down-regulated in invasive ductal carcinoma (IDC) relative to ductal carcinoma in situ (DCIS, non-invasive).	6	1.051289e-2	1.000000e+0	1.000000e+0	9.512129e+1	1.051289e-2	1	1.051289e-2	1.000000e+0	7	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	SLC19A2
MSigDB Perturbation	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	Genes down-regulated in brain relapse of breast cancer.	7	1.181420e-2	1.000000e+0	1.000000e+0	8.464389e+1	1.181420e-2	1	1.181420e-2	1.000000e+0	5	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	SLC19A2
MSigDB Perturbation	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	Genes up-regulated in bone relapse of breast cancer.	8	1.216498e-2	1.000000e+0	1.000000e+0	8.220318e+1	1.216498e-2	1	1.216498e-2	1.000000e+0	8	1.006297e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	SLC19A2
MSigDB Perturbation	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	Genes from the blue module which are up-regulated in HAEC cells (primary aortic endothelium) after exposure to the oxidized 1-palmitoyl-2-arachidonyl-sn-3-glycerophosphorylcholine (oxPAPC).	9	1.272644e-2	1.000000e+0	1.000000e+0	7.857656e+1	1.272644e-2	1	1.272644e-2	1.000000e+0	10	1.336928e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	SLC19A2
MSigDB Perturbation	QI_HYPOXIA	Genes up-regulated by hypoxia in TRAMP-C cells (prostatic cancer).	10	1.553739e-2	1.000000e+0	1.000000e+0	6.436085e+1	1.553739e-2	1	1.553739e-2	1.000000e+0	11	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	SLC19A2
MSigDB Perturbation	DOANE_RESPONSE_TO_ANDROGEN_UP	Genes up-regulated in MDA-MB-453 cells (class A ER(-) [GeneID=2099] breast cancer) after exposure to the androgen R1881 [PubChem=13766].	11	1.585908e-2	1.000000e+0	1.000000e+0	6.305535e+1	1.585908e-2	1	1.585908e-2	1.000000e+0	15	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	SLC19A2
MSigDB Perturbation	GROSS_HYPOXIA_VIA_ELK3_UP	Genes up-regulated in SEND cells (skin endothelium) at hypoxia with ELK3 [GeneID=2004] knockdown by RNAi.	12	1.692654e-2	1.000000e+0	1.000000e+0	5.907883e+1	1.692654e-2	1	1.692654e-2	1.000000e+0	19	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	SLC19A2
MSigDB Perturbation	ZHANG_TLX_TARGETS_36HR_UP	Genes up-regulated in neural stem cells (NSC) at 36 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	13	1.763612e-2	1.000000e+0	1.000000e+0	5.670181e+1	1.763612e-2	1	1.763612e-2	1.000000e+0	22	2.456936e-2	1.000000e+0	1.000000e+0	4.045067e+1	2.472147e-2	1	223	5.000000e-1	4.484305e-3	unnamed	SLC19A2
MSigDB Perturbation	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	Genes up-regulated in apoptotic tissues (neuroepithelium) after MDM4 [GeneID=4194] knockout.	14	1.902804e-2	1.000000e+0	1.000000e+0	5.255401e+1	1.902804e-2	1	1.902804e-2	1.000000e+0	14	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	SLC19A2
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_6HR_DN	Genes down-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 6h.	15	2.009742e-2	1.000000e+0	1.000000e+0	4.975762e+1	2.009742e-2	1	2.009742e-2	1.000000e+0	13	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	SLC19A2
MSigDB Perturbation	ZWANG_EGF_INTERVAL_DN	Genes repressed in the time interval between two pulses of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	16	2.135277e-2	1.000000e+0	1.000000e+0	4.683233e+1	2.135277e-2	1	2.135277e-2	1.000000e+0	18	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	CCDC181
MSigDB Perturbation	SMID_BREAST_CANCER_LUMINAL_B_UP	Genes up-regulated in the luminal B subtype of breast cancer.	17	2.166873e-2	1.000000e+0	1.000000e+0	4.614944e+1	2.166873e-2	1	2.166873e-2	1.000000e+0	12	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	SLC19A2
MSigDB Perturbation	KIM_MYC_AMPLIFICATION_TARGETS_UP	Genes positively correlated with amplifications of MYC [GeneID=4609] in SCLC (small cell lung cancer) cell lines.	18	2.171723e-2	1.000000e+0	1.000000e+0	4.604639e+1	2.171723e-2	1	2.171723e-2	1.000000e+0	16	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	SLC19A2
MSigDB Perturbation	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	Genes up-regulated in MCF7 cells (breast cancer) at 6 h of estradiol [PubChemID=5757] treatment.	19	2.250191e-2	1.000000e+0	1.000000e+0	4.444068e+1	2.250191e-2	1	2.250191e-2	1.000000e+0	21	2.445986e-2	1.000000e+0	1.000000e+0	4.063288e+1	2.461061e-2	1	222	5.000000e-1	4.504505e-3	unnamed	SLC19A2
MSigDB Perturbation	LI_INDUCED_T_TO_NATURAL_KILLER_UP	Genes up-regulated in ITNK cells (T-lymphocyte progenitors (DN3 cells) reprogrammed to natural killer (NK) cells by ablation of BCL11B [GeneID=64919] gene), compared to the parental DN3 cells.	20	2.276746e-2	1.000000e+0	1.000000e+0	4.392234e+1	2.276746e-2	1	2.276746e-2	1.000000e+0	27	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	SLC19A2
MSigDB Perturbation	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP	Genes up-regulated in non-apoptotic tissues (fetal liver) after MDM4 [GeneID=4194] knockout.	21	2.320298e-2	1.000000e+0	1.000000e+0	4.309791e+1	2.320298e-2	1	2.320298e-2	1.000000e+0	20	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	SLC19A2
MSigDB Perturbation	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	Genes down-regulated in nsopharyngeal carcinoma relative to the normal tissue.	22	2.358660e-2	1.000000e+0	1.000000e+0	4.239696e+1	2.358660e-2	1	2.358660e-2	1.000000e+0	25	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	CCDC181
MSigDB Perturbation	KONDO_PROSTATE_CANCER_WITH_H3K27ME3	Top 200 genes with high histone H3 trimethylation mark at K27 (H3K27me3) in PC3 cells (prostate cancer), by ChIP-chip assay on an 88K microarray (all promoters).	23	2.435971e-2	1.000000e+0	1.000000e+0	4.105140e+1	2.435971e-2	1	2.435971e-2	1.000000e+0	17	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	CCDC181
MSigDB Perturbation	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	Genes whose expression in optimally debulked ovarian tumors is associated with survival prognosis.	24	2.457305e-2	1.000000e+0	1.000000e+0	4.069499e+1	2.457305e-2	1	2.457305e-2	1.000000e+0	1	1.660913e-4	5.587311e-1	5.587311e-1	7.742918e+1	2.583005e-2	2	233	1.000000e+0	8.583691e-3	unnamed	CCDC181,SLC19A2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_20HR_UP	Genes up-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 20 h time point that were not up-regulated at the previous time point, 18 h.	25	2.499741e-2	1.000000e+0	1.000000e+0	4.000415e+1	2.499741e-2	1	2.499741e-2	1.000000e+0	23	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	CCDC181
MSigDB Perturbation	FORTSCHEGGER_PHF8_TARGETS_UP	Genes up-regulated in HeLa cells (cervical carcinoma) upon knockdown of PHF8 [GeneID=23133] by RNAi.	26	3.047209e-2	1.000000e+0	1.000000e+0	3.281692e+1	3.047209e-2	1	3.047209e-2	1.000000e+0	24	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	SLC19A2
MSigDB Perturbation	ZHANG_TLX_TARGETS_60HR_UP	Genes up-regulated in neural stem cells (NSC) at 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	27	3.152082e-2	1.000000e+0	1.000000e+0	3.172507e+1	3.152082e-2	1	3.152082e-2	1.000000e+0	27	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	SLC19A2
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	The 'group 4 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 but not ERBB2 [GeneID=2099;2064].	28	3.519695e-2	1.000000e+0	1.000000e+0	2.841155e+1	3.519695e-2	1	3.519695e-2	1.000000e+0	26	3.178240e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	SLC19A2
MSigDB Perturbation	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	Transcripts depleted in pseudopodia of NIH/3T3 cells (fibroblast) in response to the chemotactic migration stimulus by lysophosphatidic acid (LPA) [PubChem=3988].	29	3.695199e-2	1.000000e+0	1.000000e+0	2.706214e+1	3.695199e-2	1	3.695199e-2	1.000000e+0	33	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	SLC19A2
MSigDB Perturbation	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	Genes which best discriminated between two groups of breast cancer according to the status of ESR1 and AR [GeneID=2099;367]: basal (ESR1- AR-) and luminal (ESR1+ AR+).	30	4.119949e-2	1.000000e+0	1.000000e+0	2.427215e+1	4.119949e-2	1	4.119949e-2	1.000000e+0	30	3.537888e-2	1.000000e+0	1.000000e+0	2.801398e+1	3.569647e-2	1	322	5.000000e-1	3.105590e-3	unnamed	SLC19A2
MSigDB Perturbation	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	Genes which best discriminate between two groups of breast cancer according the status of ESR1 and AR [GeneID=2099;367]: apocrine (ESR1- AR+) vs basal (ESR1- AR-).	31	4.240436e-2	1.000000e+0	1.000000e+0	2.358248e+1	4.240436e-2	1	4.240436e-2	1.000000e+0	29	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	SLC19A2
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) exposed to doxorubicin [PubChem=31703] in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	32	4.262412e-2	1.000000e+0	1.000000e+0	2.346089e+1	4.262412e-2	1	4.262412e-2	1.000000e+0	35	6.519651e-2	1.000000e+0	1.000000e+0	1.508445e+1	6.629344e-2	1	598	5.000000e-1	1.672241e-3	unnamed	SLC19A2
MSigDB Perturbation	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	Transcripts depleted from pseudopodia of NIH/3T3 cells (fibroblast) in response to haptotactic migratory stimulus by fibronectin, FN1 [GeneID=2335].	33	5.127776e-2	1.000000e+0	1.000000e+0	1.950163e+1	5.127776e-2	1	5.127776e-2	1.000000e+0	36	7.161666e-2	1.000000e+0	1.000000e+0	1.370897e+1	7.294496e-2	1	658	5.000000e-1	1.519757e-3	unnamed	SLC19A2
MSigDB Perturbation	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	Class I of genes transiently induced by EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	34	6.194948e-2	1.000000e+0	1.000000e+0	1.614218e+1	6.194948e-2	1	6.194948e-2	1.000000e+0	34	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	SLC19A2
MSigDB Perturbation	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	Genes with promoters bound by both PPARG and RXRA [GeneID=5468, 6256] at 8 day time point of adipocyte differentiation of 3T3-L1 cells (preadipocyte).	35	6.300120e-2	1.000000e+0	1.000000e+0	1.587271e+1	6.300120e-2	1	6.300120e-2	1.000000e+0	41	9.496795e-2	1.000000e+0	1.000000e+0	1.027392e+1	9.733385e-2	1	878	5.000000e-1	1.138952e-3	unnamed	SLC19A2
MSigDB Perturbation	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	Genes up-regulated in cultured stromal stem cells from adipose tissue, compared to the freshly isolated cells.	36	6.459289e-2	1.000000e+0	1.000000e+0	1.548158e+1	6.459289e-2	1	6.459289e-2	1.000000e+0	32	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	SLC19A2
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	37	6.654607e-2	1.000000e+0	1.000000e+0	1.502718e+1	6.654607e-2	1	6.654607e-2	1.000000e+0	40	9.285739e-2	1.000000e+0	1.000000e+0	1.051340e+1	9.511668e-2	1	858	5.000000e-1	1.165501e-3	unnamed	SLC19A2
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	38	7.551862e-2	1.000000e+0	1.000000e+0	1.324177e+1	7.551862e-2	1	7.551862e-2	1.000000e+0	44	1.189586e-1	1.000000e+0	1.000000e+0	8.148600e+0	1.227205e-1	1	1107	5.000000e-1	9.033424e-4	unnamed	SLC19A2
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	39	7.774937e-2	1.000000e+0	1.000000e+0	1.286184e+1	7.774937e-2	1	7.774937e-2	1.000000e+0	42	1.027556e-1	1.000000e+0	1.000000e+0	9.475315e+0	1.055374e-1	1	952	5.000000e-1	1.050420e-3	unnamed	SLC19A2
MSigDB Perturbation	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	Genes down-regulated in the urogenital sinus (UGS) of day E16 females exposed to the androgen dihydrotestosterone [PubChem=10635] for 48 h.	40	7.798954e-2	1.000000e+0	1.000000e+0	1.282223e+1	7.798954e-2	1	7.798954e-2	1.000000e+0	31	4.558673e-2	1.000000e+0	1.000000e+0	2.168389e+1	4.611718e-2	1	416	5.000000e-1	2.403846e-3	unnamed	SLC19A2
MSigDB Perturbation	SMID_BREAST_CANCER_BASAL_DN	Genes down-regulated in basal subtype of breast cancer samles.	41	8.172677e-2	1.000000e+0	1.000000e+0	1.223589e+1	8.172677e-2	1	8.172677e-2	1.000000e+0	37	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	SLC19A2
MSigDB Perturbation	GEORGES_TARGETS_OF_MIR192_AND_MIR215	Genes down-regulated in HCT116 cells (colon cancer) by expression of MIR192 or MIR215 [GeneID=406967;406997] at 24 h.	42	9.671084e-2	1.000000e+0	1.000000e+0	1.034010e+1	9.671084e-2	1	9.671084e-2	1.000000e+0	39	9.137854e-2	1.000000e+0	1.000000e+0	1.068780e+1	9.356466e-2	1	844	5.000000e-1	1.184834e-3	unnamed	SLC19A2
MSigDB Perturbation	BRUINS_UVC_RESPONSE_LATE	Late response genes: differentially expressed only 12 h after UV-C irradiation of MEF cells (embryonic fibroblast).	43	1.021113e-1	1.000000e+0	1.000000e+0	9.793235e+0	1.021113e-1	1	1.021113e-1	1.000000e+0	43	1.178136e-1	1.000000e+0	1.000000e+0	8.230383e+0	1.215010e-1	1	1096	5.000000e-1	9.124088e-4	unnamed	CCDC181
MSigDB Perturbation	GOZGIT_ESR1_TARGETS_DN	Genes down-regulated in TMX2-28 cells (breast cancer) which do not express ESR1 [GeneID=2099]) compared to the parental MCF7 cells which do.	44	1.109780e-1	1.000000e+0	1.000000e+0	9.010794e+0	1.109780e-1	1	1.109780e-1	1.000000e+0	38	7.897249e-2	1.000000e+0	1.000000e+0	1.240784e+1	8.059420e-2	1	727	5.000000e-1	1.375516e-3	unnamed	SLC19A2
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_UP	Genes up-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	45	1.332338e-1	1.000000e+0	1.000000e+0	7.505605e+0	1.332338e-1	1	1.332338e-1	1.000000e+0	46	1.575486e-1	1.000000e+0	1.000000e+0	6.086707e+0	1.642924e-1	1	1482	5.000000e-1	6.747638e-4	unnamed	CCDC181
MSigDB Perturbation	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY	Genes transiently induced only by the second pulse of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	46	1.379154e-1	1.000000e+0	1.000000e+0	7.250823e+0	1.379154e-1	1	1.379154e-1	1.000000e+0	45	1.522491e-1	1.000000e+0	1.000000e+0	6.308042e+0	1.585278e-1	1	1430	5.000000e-1	6.993007e-4	unnamed	CCDC181
MSigDB Predicted Promoter Motifs	RYTGCNWTGGNR_UNKNOWN	Motif RYTGCNWTGGNR (no known TF)	1	1.202590e-2	1.000000e+0	1.000000e+0	8.315386e+1	1.202590e-2	1	1.202590e-2	1.000000e+0	1	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	CCDC181
MSigDB Predicted Promoter Motifs	V$RFX1_02	Motif NNGTNRCNATRGYAACNN matches RFX1: regulatory factor X, 1 (influences HLA class II expression)	2	2.639994e-2	1.000000e+0	1.000000e+0	3.787888e+1	2.639994e-2	1	2.639994e-2	1.000000e+0	2	2.828851e-2	1.000000e+0	1.000000e+0	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	CCDC181
MSigDB Predicted Promoter Motifs	RCGCANGCGY_V$NRF1_Q6	Motif RCGCANGCGY matches NRF1: nuclear respiratory factor 1	3	6.425044e-2	1.000000e+0	1.000000e+0	1.556410e+1	6.425044e-2	1	6.425044e-2	1.000000e+0	3	9.486248e-2	1.000000e+0	1.000000e+0	1.028563e+1	9.722299e-2	1	877	5.000000e-1	1.140251e-3	unnamed	CCDC181
MSigDB Predicted Promoter Motifs	TTGTTT_V$FOXO4_01	Motif TTGTTT matches MLLT7: myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7	4	2.767434e-1	1.000000e+0	1.000000e+0	3.613455e+0	2.767434e-1	1	2.767434e-1	1.000000e+0	5	2.050899e-1	1.000000e+0	1.000000e+0	4.611708e+0	2.168394e-1	1	1956	5.000000e-1	5.112474e-4	unnamed	SLC19A2
MSigDB Predicted Promoter Motifs	AACTTT_UNKNOWN	Motif AACTTT (no known TF)	5	2.964325e-1	1.000000e+0	1.000000e+0	3.373449e+0	2.964325e-1	1	2.964325e-1	1.000000e+0	4	1.917900e-1	1.000000e+0	1.000000e+0	4.950878e+0	2.019844e-1	1	1822	5.000000e-1	5.488474e-4	unnamed	CCDC181
MSigDB miRNA Motifs	GGGACCA,MIR-133A,MIR-133B	Targets of MicroRNA GGGACCA,MIR-133A,MIR-133B	1	1.797265e-2	1.000000e+0	1.000000e+0	5.564011e+1	1.797265e-2	1	1.797265e-2	1.000000e+0	1	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	SLC19A2
MSigDB miRNA Motifs	CTGAGCC,MIR-24	Targets of MicroRNA CTGAGCC,MIR-24	2	2.419205e-2	1.000000e+0	1.000000e+0	4.133589e+1	2.419205e-2	1	2.419205e-2	1.000000e+0	2	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	SLC19A2
MSigDB miRNA Motifs	GTACTGT,MIR-101	Targets of MicroRNA GTACTGT,MIR-101	3	4.071928e-2	1.000000e+0	1.000000e+0	2.455839e+1	4.071928e-2	1	4.071928e-2	1.000000e+0	3	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	SLC19A2
MSigDB miRNA Motifs	ACCAAAG,MIR-9	Targets of MicroRNA ACCAAAG,MIR-9	4	7.022342e-2	1.000000e+0	1.000000e+0	1.424026e+1	7.022342e-2	1	7.022342e-2	1.000000e+0	4	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	SLC19A2
InterPro	IPR026687	Uncharacterised protein C1orf114	1	3.915496e-5	3.689180e-1	3.689180e-1	2.553955e+4	3.915496e-5	1	3.915496e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CCDC181
InterPro	IPR028338	Thiamine transporter 1	2	4.190995e-5	3.948755e-1	1.974378e-1	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
InterPro	IPR002666	Reduced folate carrier	3	2.229109e-4	1.000000e+0	7.000888e-1	4.486097e+3	2.229109e-4	1	2.229109e-4	1.000000e+0	3	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	SLC19A2
InterPro	IPR016196	Major facilitator superfamily domain, general substrate transporter	4	1.002249e-2	1.000000e+0	1.000000e+0	9.977556e+1	1.002249e-2	1	1.002249e-2	1.000000e+0	4	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	SLC19A2
TreeFam	TF331115	CCDC181	1	3.915496e-5	3.181732e-1	3.181732e-1	2.553955e+4	3.915496e-5	1	3.915496e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CCDC181
TreeFam	TF313684	SLC19A1, SLC19A2, SLC19A3	2	1.652385e-4	1.000000e+0	6.713640e-1	6.051859e+3	1.652385e-4	1	1.652385e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	SLC19A2
HGNC Gene Families	SLC	SLC	1	3.126915e-2	1.000000e+0	1.000000e+0	3.198041e+1	3.126915e-2	1	3.126915e-2	1.000000e+0	1	4.070677e-2	1.000000e+0	1.000000e+0	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	SLC19A2
Ensembl Genes	1546	CCDC181	1	3.915496e-5	7.063946e-1	7.063946e-1	2.553955e+4	3.915496e-5	1	3.915496e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CCDC181
Ensembl Genes	1547	SLC19A2	2	4.190995e-5	7.560974e-1	3.780487e-1	2.386068e+4	4.190995e-5	1	4.190995e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	SLC19A2
MSigDB Oncogenic Signatures	KRAS.LUNG.BREAST_UP.V1_UP	Genes up-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	1	1.793933e-2	1.000000e+0	1.000000e+0	5.574346e+1	1.793933e-2	1	1.793933e-2	1.000000e+0	1	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	CCDC181
MSigDB Oncogenic Signatures	PRC1_BMI_UP.V1_DN	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of BMI1 [Gene ID=648] gene.	2	2.085117e-2	1.000000e+0	1.000000e+0	4.795894e+1	2.085117e-2	1	2.085117e-2	1.000000e+0	2	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	SLC19A2
MSigDB Oncogenic Signatures	P53_DN.V1_DN	Genes down-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	3	2.437345e-2	1.000000e+0	1.000000e+0	4.102825e+1	2.437345e-2	1	2.437345e-2	1.000000e+0	4	2.062369e-2	1.000000e+0	9.641575e-1	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	SLC19A2
MSigDB Oncogenic Signatures	PRC2_EZH2_UP.V1_DN	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of EZH2 [Gene ID=2146] gene.	4	2.665821e-2	1.000000e+0	1.000000e+0	3.751190e+1	2.665821e-2	1	2.665821e-2	1.000000e+0	3	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	SLC19A2
MSigDB Oncogenic Signatures	KRAS.600.LUNG.BREAST_UP.V1_UP	Genes up-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	5	3.169326e-2	1.000000e+0	1.000000e+0	3.155245e+1	3.169326e-2	1	3.169326e-2	1.000000e+0	6	2.949024e-2	1.000000e+0	9.191125e-1	3.365858e+1	2.971010e-2	1	268	5.000000e-1	3.731343e-3	unnamed	CCDC181
MSigDB Oncogenic Signatures	RAF_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.	6	3.391411e-2	1.000000e+0	1.000000e+0	2.948625e+1	3.391411e-2	1	3.391411e-2	1.000000e+0	5	2.193980e-2	1.000000e+0	8.205485e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h.	1	1.054199e-2	1.000000e+0	1.000000e+0	9.485879e+1	1.054199e-2	1	1.054199e-2	1.000000e+0	30	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 4 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 4 h.	2	1.192314e-2	1.000000e+0	1.000000e+0	8.387053e+1	1.192314e-2	1	1.192314e-2	1.000000e+0	11	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	3	1.282245e-2	1.000000e+0	1.000000e+0	7.798821e+1	1.282245e-2	1	1.282245e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of naive CD8 T cells versus effector CD8 IL2RA [GeneID=3559] high T cells at.	4	1.300812e-2	1.000000e+0	1.000000e+0	7.687506e+1	1.300812e-2	1	1.300812e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN	Genes down-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].	5	1.360841e-2	1.000000e+0	1.000000e+0	7.348396e+1	1.360841e-2	1	1.360841e-2	1.000000e+0	15	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	6	1.370657e-2	1.000000e+0	1.000000e+0	7.295771e+1	1.370657e-2	1	1.370657e-2	1.000000e+0	7	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 8 h.	7	1.374471e-2	1.000000e+0	1.000000e+0	7.275528e+1	1.374471e-2	1	1.374471e-2	1.000000e+0	19	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	8	1.394933e-2	1.000000e+0	1.000000e+0	7.168801e+1	1.394933e-2	1	1.394933e-2	1.000000e+0	15	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP	Genes up-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 240 min.	9	1.407297e-2	1.000000e+0	1.000000e+0	7.105820e+1	1.407297e-2	1	1.407297e-2	1.000000e+0	22	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	10	1.417033e-2	1.000000e+0	1.000000e+0	7.056996e+1	1.417033e-2	1	1.417033e-2	1.000000e+0	15	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 10 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	11	1.435409e-2	1.000000e+0	1.000000e+0	6.966657e+1	1.435409e-2	1	1.435409e-2	1.000000e+0	19	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 14 h.	12	1.480092e-2	1.000000e+0	1.000000e+0	6.756336e+1	1.480092e-2	1	1.480092e-2	1.000000e+0	27	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 0.5 h versus the untreated cells at 0.5 h.	13	1.490294e-2	1.000000e+0	1.000000e+0	6.710084e+1	1.490294e-2	1	1.490294e-2	1.000000e+0	1	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of effector CD8 IL2RA [GeneID=3559] low T cells versus effector CD8 IL2RA [GeneID=3559] high cells.	14	1.526239e-2	1.000000e+0	1.000000e+0	6.552055e+1	1.526239e-2	1	1.526239e-2	1.000000e+0	28	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_4H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 4 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 4 h.	15	1.561088e-2	1.000000e+0	1.000000e+0	6.405788e+1	1.561088e-2	1	1.561088e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	16	1.581142e-2	1.000000e+0	1.000000e+0	6.324544e+1	1.581142e-2	1	1.581142e-2	1.000000e+0	4	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN	Genes down-regulated in comparison of B cells from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	17	1.588255e-2	1.000000e+0	1.000000e+0	6.296219e+1	1.588255e-2	1	1.588255e-2	1.000000e+0	22	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h.	18	1.596829e-2	1.000000e+0	1.000000e+0	6.262410e+1	1.596829e-2	1	1.596829e-2	1.000000e+0	34	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP	Genes up-regulated in comparison of untreated macrophages versus those cultured with M-CSF [GeneID=1435].	19	1.617175e-2	1.000000e+0	1.000000e+0	6.183623e+1	1.617175e-2	1	1.617175e-2	1.000000e+0	7	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN	Genes down-regulated in CD4 [GeneID=920] cells stimulated with strong dendritic cells (DC) versus CD4 [GeneID=920] T cells stimulated with weak DCs.	20	1.624043e-2	1.000000e+0	1.000000e+0	6.157474e+1	1.624043e-2	1	1.624043e-2	1.000000e+0	3	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP	Genes up-regulated in comparison of granulocytic myeloid derived suppressor cells (MDSC) versus neutrophils.	21	1.638402e-2	1.000000e+0	1.000000e+0	6.103509e+1	1.638402e-2	1	1.638402e-2	1.000000e+0	34	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP	Genes up-regulated in comparison of macrophages cultured with M-CSF [GeneID=1435] versus macrophages cultured with M-CSF [GeneID=1435] and IFNG [GeneID=3458].	22	1.661274e-2	1.000000e+0	1.000000e+0	6.019476e+1	1.661274e-2	1	1.661274e-2	1.000000e+0	7	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 5 versus untreated CD25- T cells at day 5.	23	1.714712e-2	1.000000e+0	1.000000e+0	5.831884e+1	1.714712e-2	1	1.714712e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	24	1.715947e-2	1.000000e+0	1.000000e+0	5.827685e+1	1.715947e-2	1	1.715947e-2	1.000000e+0	43	2.161085e-2	1.000000e+0	9.599238e-1	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP	Genes up-regulated in comparsion of WTActCD4 versus WTActCD4TGF (see Fig. 1 in the paper for details).	25	1.734409e-2	1.000000e+0	1.000000e+0	5.765653e+1	1.734409e-2	1	1.734409e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN	Genes down-regulated in comparison of monocytes treated with 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with anti-TREM1 [GeneID=54210].	26	1.734844e-2	1.000000e+0	1.000000e+0	5.764208e+1	1.734844e-2	1	1.734844e-2	1.000000e+0	6	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE14308_TH17_VS_NATURAL_TREG_UP	Genes up-regulated in comparison of Th17 cells versus natural regulatory T cell (Treg).	27	1.762400e-2	1.000000e+0	1.000000e+0	5.674080e+1	1.762400e-2	1	1.762400e-2	1.000000e+0	28	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE27786_LIN_NEG_VS_BCELL_UP	Genes up-regulated in comparison of lineage negative versus B cells.	28	1.833573e-2	1.000000e+0	1.000000e+0	5.453831e+1	1.833573e-2	1	1.833573e-2	1.000000e+0	30	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 16 h.	29	1.859484e-2	1.000000e+0	1.000000e+0	5.377836e+1	1.859484e-2	1	1.859484e-2	1.000000e+0	46	2.183015e-2	1.000000e+0	9.064258e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 1 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	30	1.875224e-2	1.000000e+0	1.000000e+0	5.332695e+1	1.875224e-2	1	1.875224e-2	1.000000e+0	2	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) cultured with YF17D vaccine for 12 h versus PBMC cultured for 3 h.	31	1.880536e-2	1.000000e+0	1.000000e+0	5.317633e+1	1.880536e-2	1	1.880536e-2	1.000000e+0	30	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 24 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 24 h.	32	1.905614e-2	1.000000e+0	1.000000e+0	5.247653e+1	1.905614e-2	1	1.905614e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP	Genes up-regulated in comparison of naive follicular B cells versus early germinal center (GC) B cells.	33	1.912890e-2	1.000000e+0	1.000000e+0	5.227693e+1	1.912890e-2	1	1.912890e-2	1.000000e+0	15	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP	Genes up-regulated in comparison of memory CD8 T cells treated with IL7 [GeneID=3574] versus those treated with IL4 [GeneID=3565].	34	1.961059e-2	1.000000e+0	1.000000e+0	5.099287e+1	1.961059e-2	1	1.961059e-2	1.000000e+0	24	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE27786_LSK_VS_CD8_TCELL_UP	Genes up-regulatd in comparison of LSK versus CD8 T cells.	35	2.011576e-2	1.000000e+0	1.000000e+0	4.971227e+1	2.011576e-2	1	2.011576e-2	1.000000e+0	11	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_T_GONDII_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii.	36	2.038595e-2	1.000000e+0	1.000000e+0	4.905340e+1	2.038595e-2	1	2.038595e-2	1.000000e+0	37	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP	Genes up-regulated in comparison of monocytes treated with anti-TREM1 [GeneID=54210] and 5000 ng/ml LPS (TLR4 agonist) versus monocytes treated with control IgG.	37	2.100856e-2	1.000000e+0	1.000000e+0	4.759964e+1	2.100856e-2	1	2.100856e-2	1.000000e+0	10	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 1 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	38	2.116845e-2	1.000000e+0	1.000000e+0	4.724012e+1	2.116845e-2	1	2.116845e-2	1.000000e+0	4	1.875769e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	170	5.000000e-1	5.882353e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells versus those treated with IL6 [GeneID=3569]  and IL23A [GeneID=51561].	39	2.140237e-2	1.000000e+0	1.000000e+0	4.672379e+1	2.140237e-2	1	2.140237e-2	1.000000e+0	19	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP	Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells activated with lamina propria dendritic cells.	40	2.171087e-2	1.000000e+0	1.000000e+0	4.605987e+1	2.171087e-2	1	2.171087e-2	1.000000e+0	30	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus thymic stromal cells.	41	2.172671e-2	1.000000e+0	1.000000e+0	4.602630e+1	2.172671e-2	1	2.172671e-2	1.000000e+0	24	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP	Genes up-regulated in comparison of naive B cells versus memory IgG IgA B cells.	42	2.180350e-2	1.000000e+0	9.915401e-1	4.586421e+1	2.180350e-2	1	2.180350e-2	1.000000e+0	14	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN	Genes down-regulated in comparison of plasmacytoid dendritic cells from LAIV influenza vaccinee at day 7 post-vaccination vesus those from TIV influenza vaccinee at day 7.	43	2.181198e-2	1.000000e+0	9.688577e-1	4.584637e+1	2.181198e-2	1	2.181198e-2	1.000000e+0	47	2.369323e-2	1.000000e+0	9.628525e-1	4.195581e+1	2.383460e-2	1	215	5.000000e-1	4.651163e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP	Genes up-regulated in comparison of naive B cells versus memory IgM B cells.	44	2.184071e-2	1.000000e+0	9.480854e-1	4.578606e+1	2.184071e-2	1	2.184071e-2	1.000000e+0	11	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	CCDC181
MSigDB Immunologic Signatures	GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN	Genes down-regulated in naive CD4 [GeneID=920] T cells from cord blood versus thymic stromal cells.	45	2.190623e-2	1.000000e+0	9.297978e-1	4.564912e+1	2.190623e-2	1	2.190623e-2	1.000000e+0	34	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells versus those treated with IL1B [GeneID=3553] and IL6 [GeneID=3569].	46	2.254917e-2	1.000000e+0	9.362808e-1	4.434753e+1	2.254917e-2	1	2.254917e-2	1.000000e+0	24	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	SLC19A2
MSigDB Immunologic Signatures	GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP	Genes up-regulated in comparison of microglia cells 1 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	47	2.438851e-2	1.000000e+0	9.911075e-1	4.100291e+1	2.438851e-2	1	2.438851e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	SLC19A2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
